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The research work described in this thesis was carried out
in the Department of Plastic Surgery, University of Natal, Durban,
from January 1981 to December 1983, under the supervision of
Professor J P Jordaan.
These studies represent original work by the author and have
not been submitted in any form to another University. Where use
was made of the work of others it has been duly acknowledged in the
text.
ABSTRACT
The purpose of the study has been primarily to draw a profile of
malignant melanoma in the different population groups inhabiting
the Natal Province and Kwa-Zulu, to compare the presentation and
incidence of the disease between these groups as well as with
similar racial groups in different countries. The data collected
then permitted to estimate which parameters were relevant in
predicting the course of the disease, as well as the results of
surgical and adjuvant therapy, and was utilized in a search for the
aetiology of the tumour.
TERMINOLOGY AND ABBREVIATIONS
MELANOMA 
Since all melanomas are malignant, the adjective malignant has been
deleted in most instances. The plural form, ending with s, has
been adopted preferably to the Greek plural form : melanomata.
CLASSIFICATION 
The following description has been used:
Lentigo maligna melanoma (LM)




Staging has been described as:
Stage I - Localized melanoma without metastases to distant or
regional lymph nodes.
Stage II - Metastases limited to regional lymph nodes.
Ila - Regional lymph node involvement at the time of surgery.
Ilb - Regional lymph node involvement occuring after excision
of the primary lesion.
Stage III - Disseminated melanoma (either visceral and/or multiple
l ymphatic metastases, or multiple cutaneous and/or
subcutaneous metastases.)
ABBREVIATIONS
BCG - Bacillus Calmette Guerin
DT IC - Dacarbazine
CCNU - Lomustine
I NTRODUCTION
In the annals of medical history, Hippocrates is the first to
mention melanoma. It is then reported in the literature, along the
centuries: Rufus of Ephesus (607 - 1207), Highmore (1651),
Bartholin (1677), Bonet (1679). (1)
Laennec discussed it before the Faculty of Medicine in Paris
in 1806 (2). He called it "La melanose" (melanosis). However, the
word melanoma, as we understand it nowadays, was first used by Carswell
in 1833 to describe pigmented malignant tumours (3). Pemberton in
1 858 performed a wide and deep dissection, carrying the level of
excision deep to the deep fascia, excising at the same time involved
l ymph nodes in the groin, a practice still accepted today (4). In
1 908, Pringle (5), following Handley's concept of permeation of the
l ymphatic vessels by malignant melanoma, was the first to adopt the
principle of "excision and dissection in continuity," meaning a
radical excision of the tumour with skin, fascia and dependant lymph
nodes in an "en bloc" excision.
Our ancestors were not immune to the disease : seven
pre-Colombian mummies, estimated to be 2400 years old, showed diffuse
metastases, mostly of the skull and extremities (6,7). This
correlates with modern findings of bone involvement by metastatic
melanoma; in the mummies skin, cutaneous tumours could still be
recognized. This is indeed a surprising discovery; as far as can be
ascertained, only the superior class of these populations qualified for
such post-mortem attention; mummies being a rare finding, that so many
presented an advanced stage of melanoma leads one to think that the
disease must have been rather common then, and this amongst a non-white
population.
3.
A comparative study of two vastly different populations living
in the same environment is therefore feasible. At the same time, it
is of interest to compare the findings resulting from the study of both
groups, with American Negroes on one side, and Australian Whites on the
other side, bearing in mind, for the latter, that Natal shares with
Queensland nearly identical latitudes, the same narrow coastal fringe
giving rise to the same escarpment and plateau westward and, lastly, a
comparable daily average number of hours of sunshine.
In so far, the surgical treatment of the primary lesion in
melanoma has been rather stereotyped and for most surgeons still consists
of a tridimensional wide excision which includes skin, fat and fascia,
often associated with a regional lymph node dissection, whether the
nodes appear clinically involved or not. It must be noted that the
word "wide" is used in a broad sense; indeed, few have committed
themselves in giving numeric values.
As for many concepts in modern surgery, the reference is to
be found in the beginning of the century; Handley's observation in
1 907 has been the cornerstone in the management of melanoma, and its
influence still prevails. Yet, in his observation, Handley was not
referring to a primary lesion but the autopsy findings of a dis-
seminated melanoma. Thus, our surgical approach to the problem has
been based on inadequate premises and can rightfully be questioned.
If one accepts the concept that malignancy arises when there
is a systemic breakdown in the host's resistance, then boosting the
i mmune system would appear to be the logical approach; yet the value
of such additional therapy is doubted by many, possibly because the
series published have been few, have involved small numbers of patients,
and have produced no definitive conclusions.
4.
Natal is shared between four population groups: Black,
White, Indian and Coloured, in order of numerical importance. Each
presents a different incidence in melanoma, when not a different type;
such a set of circumstances leads to reflection in our quest for the
aetiological factors governing the occurence of melanoma: is the
disease the stereotyped clinical manifestation of entirely different
race-related and/or habit-related factors?
CUTANEOUS MELANOMA IN THE ZULU POPULATION
6.
EPIDEMIOLOGIC SURVEY IN THE ZULU POPULATION (1977-1982) 
The present study was conducted in order to determine the
incidence rate of melanoma in the Zulu population group, its variation
in incidence over the last six years, and a profile of the affection.
This is a hospital epidemiologic study; no field survey was undertaken.
MATERIALS AND METHOD 
All cases of malignant melanoma referred to the combined
melanoma clinic, King Edward the VIllth Hospital, and to the Department
of Plastic Surgery, Wentworth Hospital, have been included in the series.
All Zulu patients presenting with such tumours, in the Natal Province
and Kwa-Zulu, are referred to both Institutions, either for primary
treatment or, if treated primarily elsewhere, for further surgery as
deemed necessary and/or palliative treatment. The figures obtained
are therefore as near a true account as possible of the number of
melanoma patients in this population group. Furthermore, since 1977,
a register is being kept, in the Oncology Department, of all new cases,
and used for follow-up.
Data collected for each case include: sex, age, region of
residence, related history, anatomic site of the lesion, size of the
lesion, clinical stage, level of invasion (8) and tumour thickness (9)
when available, type of surgery performed, medical treatment and
survival. Population statistics were obtained from the Department of
Statistics, Pretoria (last census). There was no Albino patient in the
series. Nine patients refused treatment.
GENERAL TIME TREND 
From the beginning of 1977 to the end of 1982, one hundred and
nine(109) patients were referred to either or both Institutions. (Table I)








the incidence rose from 0,22/100
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Over the six year period covered in the study the incidence has more
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FIG. I CRUDE INCIDENCE (PER 100 000 POPULATION)
GEOGRAPHIC DISTRIBUTION 
Only 17,5% of all patients lived in urban areas, the remaining
82,5% in a rural environment. In this subset of rural dwellers, 47%
lived in the coastal plain while the others were widely dispersed over
the rest of the Province.
SEX TREND
The incidence increase has affected more females than males:
over the six year period, the increase has doubled for males, trebled
8.
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FIG. II SEX RELATED INCIDENCE 
AGE TREND
Incidence according to age has been studied in ten year
intervals. The youngest patient in the series was 30, the oldest 89.
A steep rise in age-related incidence appears in the 40-50
year increment, to reach a peak in the 60-70 year group then sharply
decrease (fig. III). However, when dissociated according to sex, the
distribution presents a different pattern (fig. IV). Where most of
the tumours affecting males occur during the 40-50 year period, and then
steadily decrease in numbers, most of the female cases appear in the
60-70 increment, after a steady increase; there is a 20 year shift
9.
between the two maximums. The peak of incidence as revealed on the
histogram for cumulated figures is therefore artefactual and results
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10.
The small number of melanoma patients in the 80-90 year
increment is also likely to be artefactual; since the standard death
rates in the Zulu population are not available, a standardised
mortality ratio could not be calculated, but it is doubtful that the
number of melanomas occuring after 70 years of age should show such
a decline.
ANATOMIC DISTRIBUTION AND INCIDENCE 
In the data collected, the following sites/subsites have
been affected: Lips (lower), Hands (palm), Fingers, Leg, Feet (sole),
Toes, Nail beds (parungual lesions). In one patient, the primary
l esion could not be found. Three patients presented satellite
l esions and all were on the plantar skin.
As intuitively assumed from clinical experience, most
lesions affect the sole of the foot. In this series, all cases of
melanoma of the foot were involving, even if slightly, the lesser
pigmented skin of the sole, although at times the subsite seemed to
be more prevalent in pressure areas, namely the region covering the
head of the first metatarsal bone, the lateral side of the foot, the
heel and the plantar aspect of the first toe. The incidence for each
site/subsite is summarized in Table II.
Site Lip Hand Finger Leg Foot Toe Parungual
No. of
Patients 3 1 2 2 73 9 17 = 107
Percentage 3 1 2 2 68 8 16 = 100%
TABLE II SITE-RELATED INCIDENCE 
Site-related incidence did not vary when considered in relation
to sex groups.
HISTORY OF THE LESION 
16% of the patients related the tumour to previous trauma:
thorns, nails penetrating the sole of the foot; one patient reported
that the tumour grew soon after the removal of a splinter from a
fingernail bed, and another that the lesion appeared a few months after
he had inflicted himself a heavy hammer blow on the finger tip.
Only 12% of the patients related the lesion to a pre-existing
naevus. The African patient does not usually seek medical attention
unless he feels pain or discomfort: because melanomas are to this
regard, symptomless at the beginning, the delay between the time the
l esion was first noticed and the time of first consultation is
unfortunately long (Table III), as much as 24 and 39 months for the
two leg lesion patients.
Site Duration before diagnosis:
mean (in months)
Head and neck 8
Hand - Finger 4
Leg 31
Foot - Toe 1 2
Parungual 6
TABLE III DURATION BEFORE TREATMENT 
All tumours of the foot but one were ulcerated and infected
when first seen, as well as all lesions affecting the palmar skin of
hand and fingers.
SIZE OF THE LESIONS 
Because of the long delay before reporting for treatment,
l esions were extensive with a maximum observed of 28,2cm4 (foot
lesion). 54% of all lesions were in the 9cm2 range, 12% averaged
13cm2 .
STAGING
After investigations including chest roentgenogram,
l ymphangiogram and when deemed necessary CT scan of bones, liver and
12.
spleen, thirty six patients (33%) were classified as Stage I melanomas,
62 as Stage Ila (57%) and 11 as Stage III (10%). No particular
site-related incidence could be identified in relation to the different
stages, nor was there a sex-related trend. Twenty-seven patients
(25%) presented with ulcerated lymph nodes (26 had ulcerated inguinal
lymph nodes, one axillary ulcerated nodes). The mean number of
clinically involved lymph nodes was 3.
DEPTH OF INVASION - TUMOUR THICKNESS 
Histology reports were available for only 98 patients (9
refused treatment, in one the primary lesion could not be found).
Measurement of tumour thickness according to Breslow's technique was
not introduced before 1980 and was available for only 56 patients.
No attempts were made in obtaining tumour thickness measurements for
patients treated previously, since it could not be ascertained whether
sections made at the time of first examination had intersected the
thickest part of the speciment or not.
Levels of invasion according to Clark's classification for
each site and subsite and summarized in Table IV.





III 7 1 2
IV 1 1 1 2 30 5 5
V 2 26 3 9
TABLE IV LEVEL OF INVASION AS FUNCTION OF LOCALIZATION 
Tumour thickness measurements varied from 1,3mm - the thinnest
l esion in the series - Clark level II level of invasion - to 31mm,
1 3.
Clark level V. Levels of invasion and tumour thickness did not
correlated adequately: there was a wide dispersion of tumour thickness
values for each depth of invasion (Fig. V). The explanation to this
discrepancy is to be found in the characteristics of the skin involved:
eighty six melanomas in the series occured in the skin of the palm of
the hand and the sole of the foot: atrichal and weight-bearing skin
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FIG. V LEVEL OF INVASION VERSUS TUMOUR THICKNESS
DISCUSSION
While there is much research carried out on melanoma amongst
diverse White populations, little information is available concerning the
epidemiology of melanoma in Negro population groups. I. Kaplan and
J. Youngleson (10) reviewed all melanoma cases treated at Baragwanath
Hospital, Johannesburg, from 1951 to 1964, 98 patients over a 14 year
period; however, they calculated the incidence according to hospital
admissions and not population groups. Unlike the present series, there
was no increase in incidence rates, but similarly was noted the slightly
higher number of females, the same body distribution of the lesions and
the length of symptoms. Giraud et al (11) conducted the same survey,
in the same Hospital, and recorded a 100 cases from 1959 to 1970 (thus
14.
including patients from Kaplam and Youngleson's study); they concluded
that the incidence of melanoma in the Johannesburg Bantu population
was 1,2 per 100 000, but gave no time trend. Their incidence figure
is much higher than in the present study. John Higginson and A.G. Oettle,
in their extensive "Cancer survey in the Transvaal" (12) reported only
six cases of melanoma in the Bantu population (from which they had
included migrants working in the mines) over a three year period, while
Des Ligneris (13) mentioned the occurence of 17 melanomas from Northern
Transvaal over twenty years. More recently, Shah and Goldsmith (14)
studied the clinical behaviour of 18 cases of melanoma in American
Negroes treated during the past twenty years at the Memorial Sloan-
Kettering Cancer Center, New York, against 1483 cases of melanoma in
White patients who received treatment at the same Institution over the
same period; they made no mention of previous trauma as a possible
aetiology, but thirteen of their patients had noticed a pre-existing
mole at the site of the lesion.
Data are presently being collected by the Medical Research
Council Unit in East London, but no results have yet been published.
RACIAL BACKGROUND 
The American Negro differs genetically from any African
group since there has been admixture of different ethnic genotypes;
although most originate from the Western and Central parts of Africa,
there has been inter-marriage between Blacks, Indians and Whites.
Similarly, the Bantu population of the Johannesburg district is not
representative of a specific sub-group since the region attracts workers
from the whole sub-continent. On the contrary, the Zulu group appears
homogeneous; because of his culture and proud history, the Zulu does not
usually loosen ties with his ancestral customs; Zulus commonly marry
Zulus, and tribal discrimation is prevalent. The present survey is
therefore representative of the Zulu population only.
1 5.
ACCURACY OF THE SURVEY 
Few Zulus are conversant with either official language of the
Republic of South Africa; case histories and informations were obtained
with the assistance of an interpreter, usually a nurse.  As far as can
be ascertained, the translations were adequate.
CALCULATED RATIOS 
Two common sources of error in epidemiologic surveys are:
under-estimation of the population at risk and under-evaluation of
cases. In the present survey, under-estimation of the population at
risk is unlikely since the ratios have been calculated with figures from
the most recent census; under-evaluation of cases is possible because
of the very primitive conditions in which some members of this population
group still live (particularly in Northern Natal), with inherent travelling
difficulties.
INCIDENCE OF MELANOMA 
The study has revealed the following aspects: firstly, there
is an increase in incidence rates in the Zulu group; secondly, the
incidence increase follows a linear pattern: thirdly, there is a marked
difference in the sex-related incidence in patients over fifty years of
age. Yet, the highest incidence rate of 0,50 per 100 000 in 1982 does
not correlate with other figures for other black population groups
(Table V).
The rising incidence, however consonant with world-wide
findings concerning White population groups, does not seem to have been
reported in other Black population groups (but again, information
available is scanty and the series published small). This rise could
be the result of the following:artefactual errors, cohort effect, true
rise in incidence, the reason for which is not apparent.
16.
BLACKS Males Females Total
Nigeria (1960-1965)








Cape (1956-1962) 1,6 2,1 1,8
Natal (1964-1966) 0,9 1,2 1,0
Transvaal (1953-1955) 0,6 0,9 0,8
Johannesburg (1959-1970) 0,4 1,7 1,1
Figures given per 100 000
TABLE V INCIDENCE OF MALIGNANT MELANOMA FROM J J RIPPEY, E RIPPEY(15)
ARTEFACTUAL ERRORS 
It is possible that year after year, more patients seek medical
treatment for a lesion which was previously let to run its own course (or
treated exclusively by the local Inyanga)t Greater awareness by general
practitioners may also partially explain the increasing incidence of
referrals. Diagnostic errors can be ruled out because the patients
present with such advanced lesions that in most instances the diagnosis is
clinically unmistakable. Because the rise is linear and affects both
sex groups equally, because it is encountered throughout the Province and
has more than doubled over the six year period of the survey, it is likely
to reflect a true situation, however, difficult it is to exclude
artefactual errors completely.
COHORT EFFECT 
It is not feasible to exclude a cohort effect+ in a six year
period study.
ANATOMIC DISTRIBUTION 
The sites affected by the tumour as well as the incidence for
each site do not differ markedly from other series.(Table VII
Witch-Doctor
+ - A "Cohort" is defined as a group of individuals identified by a
common characteristic, who are studied over a period of time.
17.
The comparatively slightly higher number of melanomas affecting the sole
of the foot result from adding to lesions of the sole other lesions of
the ankle and sides of the foot, because they originated from non-
pigmented skin. There were no lesions of the dorsum of the foot nor
the hand; only two patients (1,8%) presented lesions on heavily
pigmented skin (leg lesions); it is a striking feature of melanoma in
Negroes, whether they live in Africa or in European-type societies,
that the highest incidence is to be found in non or lesser pigmented
skin, the site of predilection being the sole of the foot. This feature
invalidates the aetiological hypothesis, at least in these population
groups, of UV radiations being the responsible carcinogen.
Lower extremity (foot) 156 - 76,5% (80,4%)
Upper extremity (palms and fingers) 1 9 - 9,3% (10,7%)
Head and neck 1 2 ( 5,9%)
Trunk 6 ( 3,0%)
204
TABLE VI SITE OF MELANOMA 
(From Giraud R M et al: Malignant melanoma of the skin in Black Africans.
South African Med. J. 49, 665 (1975)(11).
SURGICAL TREATMENT AND SURVIVAL 
Surgical treatment was undertaken by different teams, not
following a standard pre-determined protocol.
TREATMENT OF THE PRIMARY LESION 
CLEARANCE MARGINS 
The mean clearance margin of excision was 2,5cm ranging from
1 to 8cm. It would seem that in most instances the limiting factor was
the localization of the lesion itself, and the surgeon's deep concern of
skin grafting a weight-bearing area when the plantar skin was involved.
1 8.
Amputation as a treatment of the primary lesion was performed
for all cases of parungual, finger and toe lesions; in these cases,
amputation was performed at the level of the metacarpo/metararso-phalangeal
joints (19 cases) or involved the whole ray (8 cases). The patients
needed much convincing when this form of surgery was offered.
ADEQUACY OF EXCISION 
Removal of the lesion was found incomplete in 12 cases, where the
deep line of resection was not free of tumour; six of these cases were
referrals from country hospitals; all were re-excised.
No prophylactic lymph node dissections were performed in Stage I
melanomas, irrespective of level of invasion or thickness of the tumour.
Local recurrence occured in sixteen cases, of which nine had an amputation
and presented a tumour arising on the surgical scar.
TREATMENT IN STAGE II AND III MELANOMAS 
RECURRENCE
Despite complete excision of 36 Stage I patients, nineteen
presented regional lymph node metastases following treatment of the
primary lesion (53%), after a mean delay of eight months, ranging
from 1 month to 17 months: likewise five such patients developed
visceral metastases (Table VII).
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Subsequent
Staging  
TABLE VII PATIENTS STAGING 
In all cases of Stage II melanoma, a radical regional lymph node
dissection was proposed; twenty-seven patients refused such treatment
and were subsequently lost for follow-up. Stage III melanoma patients
19.
were offered palliative therapy in the form of immuno-therapy (Bacillus
Calmette-Guerin injections) and chemotherapy (DTIC- CCNU): no surgery
was performed. Regular attendance for treatment was so poor as to
render the results meaningless.
SURVIVAL
The difficulties encountered in locating patients or their
relatives in order to estimate survival rates cannot be over-emphasised;
the problem is compounded even further when it is known that patients
often use different first names when registering in Hospitals. Only
seventy one case histories could be utilized to estimate crude survivals
and the number was estimated too small to draw valid conclusions regarding
level of invasion, thickness of the tumour or staging and corresponding
survival.
As could be expected from the advanced state of the tumours,




Total (71) - all cases
n = 34 n = 27
Survival
19/71 27% 18/71 25% 521 year
3 years 10/71 14% 12/71 17% 31
3 years 5/71 7% 7/71 10% 1 7
TABLE VIII CRUDE SURVIVAL RATES
DISCUSSION
Malignant melanoma in Negroes presents a monomorphous pathologic
pattern, with particular characteristics: the tumour affects non or
lesser pigmented skin, is predominant on extremities, is ulcerated and is
prevalent in weight-bearing areas. Reed (16) in 1975 introduced the
concept of acral lentiginous melanoma (ALM) to characterize those lesions
which arise on volar and subungeal skin and histologically present a phase
20.
of radial growth similar to that of mucosal melanomas. Arrington (17)
further defined the behaviour of -.Lich turnout., in a rytiospectivo study
of plantar lesions and noted that such melanomas presented a more
aggressive behaviour than the superficial spreading or lentigo maligna
types. A recent study of plantar lesions in the Black population of
Nigeria reported that 66 percent were classified as nodular, 23,8
percent superficial spreading and the remainder were unclassifiable (18).
The same doubtful classifications appeared in the present survey.
Because these tumours have the same clinical behaviour and affect always
the same anatomic sites i.e. the body extremities, they have been
regrouped as acral lesions, as a separate entity.
Acral lentiginous melanoma, first described by Sir Jonathan
Hutchinson in 1886 as a melanotic whitlow, occurs only in atrichous
skin and mucous membranes, as seen in Black patients; its evolution is
usually slow and it is not related to actinic damage. The tumour
gradually enlarges, causing no pain or physical impairment, and large
areas of skin are involved when symptoms call for attention, a clinical
behaviour which is encountered in the Black patient; it may thus be
assumed that the same type of tumour is being classified under two
different names, acral melanoma being the clinical definition of acral
l entiginous melanoma, a conclusion similarly reached by Krementz (19)
in a review of White patients presenting this type of lesion. These
melanomas have been attributed a poor prognosis; when tumour thickness
and levels of invasion are considered, they do not seem to behave more
aggressively than the other types of melanoma and certainly not the
nodular variant. The poor prognosis is rather the result of the lesion
being inconspicuous or thought inocuous over a long period. When comes
the time of surgery, in-transit metastases have long spread; improvement
in survival could certainly be achieved, should the patients seek treatment
earlier.
CUTANEOUS MELANOMA IN THE WHITE POPULATION
22.
EPIDEMIOLOGIC SURVEY IN THE WHITE POPULATION (1975-1982) 
The survey covers the seven year period from the 1st January
1 975 to the 31st December 1982.
MATERIALS AND METHOD 
Data was collected from the following sources: Department of
Oncology, Addington Hospital; Department of Plastic Surgery, Wentworth
Hospital; Doctor Duncan Taylor's Pathology Laboratory, Durban.
Messrs J L Cooke, W M M Morris and J Youngleson kindly permitted access
to their malignant melanoma patients' files which, besides allowing for
cross reference with Doctor Duncan Taylor's register, provided for
follow-up and history of a great number of patients.
Both Departments of Oncology and Plastic Surgery work in close
relationship as regards the treatment of skin malignancies; moreover,
the Oncology Department deals with many patients referred by Plastic
and General Surgeons in private practice for the purpose of medical
treatment of the disease after surgery, or for palliative treatment when,
for various reasons, surgery was not possible.
In the absence of an official Cancer Registry, the figures
obtained are thought to be as accurate as possible in the circumstances.
Data collected for each patient include: age, sex, region of
residence, occupation, related history, site or subsite of the primary
lesion, depth of invasion and tumour thickness when available, type of
surgery performed, subsequent treatment and survival. Population
statistics were obtained from the Department of Statistics, Pretoria
(last census).
GENERAL TIME TREND 
From the beginning of 1975 to the end of 1982, 545 patients
presented with a malignant melanoma. However, although this figure
could be used to determine the population incidence, in 37 cases full
data could not be obtained as regards the other parameters to be studied:
23.
in three cases "shave-biopsies" had been performed, which did not allow
for full histological reports: one case presented with disseminated
melanoma after the primary lesion had been cauterized three years
previously, no histology report was available.
for each year are as follows:- (Table I)








7,4 6,2 7,9 12,4 11,9 14,3 15,6 15,8
TABLE I YEARLY INCIDENCE 
The mean interval between time of occurence of the tumour
and/or onset of changes in a pre-existing lesion and time of first
consultation was 19,3 months, with extremes ranging from 3 months to
48 months.
With a White population in Natal and Kwa-Zulu of 595 820, the
incidence has risen from 7,4 to 16 per 100 000 population. Over the
8 year period of the study, the incidence has more than doubled, (Fig. I)
equally affecting men and women with a female to male ration of 1,2/1
( Fig. II). The years 1977 and 1978 showed a considerable increase, to
be followed by more stability.
AGE TREND
Age incidence rates were determined for each ten year groups;
the youngest patient was 9, the oldest 84. There is a steep rise in
incidence in the 3rd and 4th decades, a moderate decrease in the fifth
and maximum incidence in the seventh increment. (Fig.II)
When dissociated according to sex (Fig. III) males show a
steadily increasing incidence with a peak at the sixth decade, while













seventh decades, which might indicate a heterogeneous population,
possibly related to different hormonal conditions, before and after
menopause. It must be noted that both sex groups show the same
reduced incidences in the fifth age group. The sharp decline in the
eighth and ninth increments is artefactual and results from the small
number of cases seen in these age groups. (Standardised incidence
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FIG. I CRUDE INCIDENCE (PER 100 000 POPULATION) 
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FIG. III INCIDENCE ACCORDING TO SEX AND AGE 
REGION OF RESIDENCE, OCCUPATION 
Although the patients studied in this series come from the whole
Province, 79,4% proved to be urban dwellers (n = 433) and 20,5% to be
living in rural areas, (h = 112) giving a 4 : 1 ratio while the urban/
rural ratio for the White population in the Province and Kwa-Zulu is
6 : 1. Furthermore, of the rural population, 60% (n = 67) were found
to be concentrated along a 70 kilometre wide coastal fringe.  Only 2,6%
(n = 3) of all rural persons presenting with a melanoma happened to have
indoor occupations, against 73% amongst urban residents (n = 316).
RELATED HISTORY 
The tumour was related to a pre-existing mole by 30% of the
patients (n = 153), alternatively to a "birth-mark"; often the lesion
was described as a mole which gradually enlarged and became darker, or
itchy, or bled. Only two patients (0,36%) related the lesion to
previous trauma: in one case a wound of the big toe which subsequently
failed to heal, in the second case a wound of the knee on a long standing
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LL : Lower limb
26.
ANATOMIC DISTRIBUTION 
The following sites have been considered: Head and neck,
upper limbs, back, chest, abdomen and lower limb.
The overall incidence of "head and neck" and "lower limb"
tumours is similar; upper limb and back lesions show also a comparable
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FIG. IV SITE RELATED INCIDENCE 
However, when dissociated according to sex, the distribution
shows a different pattern. (Fig. V)
Males present a high percentage of lesions of the head and neck
and back, whereas females present a higher number of lesions of both
upper and lower limbs. The relative rarity of chest and abdomen lesions
is identical to both groups. Of the lower limb lesions in females, leg
tumours accounted for 83%, while thigh lesions represented only 17%; of
the upper limb lesions in females, arm and forearm lesions represented
56% and 44% respectively. Ear lesions in males accounted for 32% of
all head and neck lesions, but cheek lesions for only 8%. The nose gave
rise to a tumour in only one case.
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HN : Head and neck




LL : Lower limb
FIG. V SITE INCIDENCE ACCORDING TO SEX
AGE AND SITE 
A possible relationship between age and site has been
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FIG. VI AGE AND SITE INCIDENCE (HEAD/NECK, UPPER LIMB, LOWER LIMB) 
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FIG. VII AGE AND SITE INCIDENCE (BACK, CHEST, ABDOMEN) 
A remarkable feature of the head and neck lesions is the high
incidence in the last three decades, a moderate peak in the second decade
and the less number of lesions in mid-life. Upper and lower limb lesion
frequencies show a rather disorganized pattern but their mean values do not
differ much (13<(;(<16,7). The high incidence of back and abdomen
l esions in the first decade is artefactual and results from the small
number of cases represented in this age group; it is evident, however,
that back lesions are most common between the fourth and sixth decades,
and that chest and abdomen melanomas incidence decreases steadily
after the second decade and would appear, therefore to be tumours
arising in young persons.
HISTOLOGICAL TYPE IN RELATION TO SEX AGE AND SITE
The occurance of the five types of malignant melanoma:
Lentigo maligna, nodular, superficial spreading, acral and amelanotic
has been studied in relation to the following parameters: sex, age, and
anatomic distribution.
2 9.
SEX AND HISTOLOGICAL TYPE
The results are represented in Table II.









Nodular 50,4 114 41,8 118 232
Superficial Spreading 32,3 73 32 125 198
Lentigo Maligna 7 16 12,4 35 51
Acral 1,7 4 1,4 4 8
Amelanotic 8,4 19 0 0 19
TABLE  II HISTOLOGICAL TYPE IN SEX GROUPS 
It appears that the nodular type was slightly more common
amongst males, and also the commonest lesion and that, in this series,
the amelanotic type affected males only. Superficial spreading lesions
were equally shared between the two sex groups, as well as the acral types.
Lentigo maligna was found to be more prevalent in the female group.
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FIG. VIII HISTOLOGICAL TYPE DISTRIBUTION IN AGE GROUPS
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No conclusion could be derived from the present data about the acral
and amelanotic variant because these lesions were too few in numbers.
(respectively 1,5% and 3,7%)
The curves related to nodular, superficial spreading and
l entigo maligna types show interesting characteristics: nodular
melanomas present an overall high incidence with a peak at the fourth
and seventh decades; superficial spreading lesions are prevalent
during the first five decades and then show a rapid incidence drop;
l astly, lentigo maligna prevails in the last decades of life, with a
sudden increase in the seventh 10 year age group.
It can be concluded that the superficial spreading type
affects the rather young population cohort, lentigo maligna the not so
young, and nodular melanomas affects everyone.
SITE AND HISTOLOGICAL TYPE 
The relative incidence of the five melanoma types was
studied in relation to the following anatomic sites: head and neck,
upper limb, back, chest, abdomen and lower limb. (Fig. Ix)
Nodular and superficial spreading types accounted, in close
proportions, for most lesions of the upper limb, lower limb and back.
On the head and neck, both the nodular and lentigo maligna
types prevailed. A reversal in incidence appears between nodular and
superficial spreading lesions of the chest and abdomen. Besides the
head and neck site, lentigo maligna accounted for only a few lesions on
upper and lower limbs and was present neither on back, chest nor abdomen.
Amelanotic lesions were found in three sites only : back, chest and lower
limb. Acral melanoma, in this series, affected only the lower limb
(Plantar skin and toes).
LEVEL OF INVASION : TUMOUR THICKNESS 
Levels of invasion were recorded according to Clark's classification,
































































Breslow's technique was not utilized before 1980; no requests were
made for earlier tumours to be so measured, because one cannot be
sure that previous sections have not intersected the thickest part of
the specimen already, and measurements of the remnants may give
erroneous results; thus tumour thickness was available for only
242 specimens.-
The incidence for each level of invasion is represented in
Table III.   
Clark's 
Level
I II III I V V Total
5,1 23 30,5 31 10,4 100%




patients    
TABLE III LEVEL OF INVASION 
There was no significant difference between males and females;
however, patients who reported to hospital clinics for treatment of a
primary lesion presented tumours which averaged deeper levels of invasion
than lesions excised from patients privately treated. This trend may
be explained by the different socio-economic status of these subsets of
patients.
Clark's levels of invasion and tumour thickness have been
matched (Fig. X) for the 242 available thickness measurements. It
appears that level of invasion and tumour thickness correlate well only
for Clark's level II; there is much dispersion of thickness values in
Clark's level III, IV and V, but particularly level IV.
The implications of such poor correlation will be examined
in conjunction with survival rate.
The size of the lesions was studied in relation to level of







correlation exists between the two parameters.
Clarks' Level
of Invasion
I II III IV V
Size of Tumour 
(Mean, in mm) 
16 8,9 15,2 11,1 13,8
TABLE IV LEVEL OF INVASION AND SIZE
DISCUSSION
The rising incidence of melanoma appears to be a worldwide
phenomenon among White population groups (20-21-22) and with reference
to the results of the present survey, South Africa is no exception.
Yet, despite close similarities in geographical features, and
although amongst the highest, incidence in South Africa is lower than
in the Australian Queensland (35/100 000 in 1977), not even close to
New South Wales findings of 22/100 000 for the same year, but where a
doubling in incidence rates over a seven year period has been reported.
(Fig. XI) (22). There is no previous report of such an increase in






































This increase in incidence can result from the following
factors
Artefactual errors - lesions which were previously classified
as non-malignant.
A cohort effect, whereby a susceptible population group
happens to be included in the survey.
3. A true rise in incidence, a possible aetiology of which will
be proposed further.
ARTEFACTUAL ERRORS
it is possible that more early stage lesions are now being
excised; such tumours, labelled melanoma in situ" were and are often
denied malignant potential, and have been included in the survey.
Their number is however so small (n=26) that they cannot account solely
for the rise in incidence; diagnostic errors can be ruled out because
histological sections were examined by trained pathologists in all cases.
Since similar reports originate from different countries, because the
increase affects both sex and age groups and presents a near linear
increase, it can be concluded that the rise is real and not artefactual.
COHORT EFFECT
A cohort effect cannot be assessed in an eight year survey.
The near linear pattern of the increase together with the involvement of
all age groups argue against, but do not allow for exclusion of such an
explanation,
VALIDITY OF RESULTS
The validity of the results can be questioned in terms of
over and/or underestimation.
- overestimation is unlikely, since it could only result from erroneous
histological diagnosis and, as previously stated, all specimens were
examined by trained pathologists.
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- underestimation remains a possibility. It still unfortunately
happens that lesions be cauterized by a medical practitioner, or
shaved; three such patients history appeared in the data and it is
likely that such form of treatment is still carried out without our
being able to assess how often.
It is also possible that patients living on the borders of the
Province may seek medical attention outside these boundaries, but it may
be assumed that this would apply to few patients. Likewise, it may be
that patients from the neighbouring provinces may seek treatment in
Natal for convenience, and it may be assumed that their numbers in either
groups would balance.
OCCUPATION - RELATED HISTORY 
In recent years, it has become apparent that the incidence of
melanoma in Whites correlates with socio-economic status, both sex
groups being equally affected. Furthermore, outdoor work does not seem
to predispose to a high incidence for a similar socio-economic status. (23)
As regards this particular epidemiological aspect of melanoma,
the present survey is of necessity biased since the number of urban
dwellers and indoor workers by far exceeds the number of outdoor
workers in rural areas; thus conclusions must be considered with caution.
These short-comings being appraised, the results of the survey are
consonant with Lee and Strickland's findings (23) as well as others
(24-25), although the data could not be broken down in subsets according
to socio-economic status through lack of information in this regard.
Authors who published on this particular aspect of the disease dealt
with population groups from northern countries, U S A, Britain,
Scandinavia, and the explanation proposed a greater but mostly brief
and intense sun exposure through facilitated travel to sunny countries
permitted by high social status. But in South Africa, irrespective of
35.
of income, everyone gets more than his fair share of sunlight daily,
willingly or not, and this hypothesis fails to enlighten the problem
in our country. Another explanation must be found.
The occurence of a melanoma in or from a pre-existing naevus
has been diversely appreciated and reported, as well as trauma. This
aspect will be discussed in the chapter devoted to the aetiology of
melanoma.
As regards growth patterns in relation to age, sex and site,
the findings do not differ from those reported elsewhere (26-27), but,
as mentioned, the nodular type of lesion appeared to be the commonest,
unlike other series where the superficial spreading type was the most
prevalent.
SURGICAL TREATMENT AND SURVIVAL
Except for a subset of 49 patients treated by one surgeon
(self) in the Department of Plastic Surgery, lesions have been excised
in various Hospitals by different surgeons.
The results of surgical and subsequent medical treatment
could be followed on only 164 patients, namely patients who happened
to be hospital patients, whose files were really available or, when
privately treated patients, whose files were made accessible. Thus,
rates of recurrence, occurence of metastases, medical treatment and
survival could be studied on this subset only.
SURGERY OF THE PRIMARY LESION IN STAGE I MELANOMA 
1. Biopsy : Biopsy results were available for 508 patients with the
following findings:
No incisional biopsies were performed. A wedge excision
of the lesion was carried out in 19% (n=96) against
excision and skin graft in 81% (n=412).
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A positive clinical diagnosis, as reflected on the
histology request form was made in 62% of cases (n=314).
2. Adequacy of excision :
Only three excision biopsies happened to be incomplete,
two of them leading to re-excision; the third one did not
trigger such response and was soon followed by a recurrence
(4 months delay).
The available data for the 164 patients as defined above showed that,
following histology results, and although excisions proved complete,
in 43 patients (38,7%) a re-excision was carried out with wide margins,
and wound cover achieved by split-thickness grafts in 156 patients (95%),
full-thickness graft in 3 patients (2%) and flap in 5 patients (30).
One amputation was performed, for a toe lesion. No malignant cells
were ever found in re-excision specimen when the excision biopsy had
been complete.
3. Excision margins : The clearance margin from the tumour varied
between 0,8cm to 10cm with a mean 4,3cm, the wider margins for trunk
lesions, the smaller for head and neck lesions. The concept of wide
clearance margins let, however, to widely different interpretations ;
where some defined their measurements as the diameter of the excision,
many did not perform a circular excision and used different measurements
in width and length, with a mean width/length ratio of 1 : 2; as a
result, the lines of excision in width were never found to be more than
2,4cm (mean) from the site of the tumour, with extremes ranging from 1,5cm
to 4cm, thereby, in most instances negating the whole concept.
The excision usually affected the shape of an ellipse, with
the site of the lesion as one of the foci, and the great axis in a
proximalward direction in order, it is believed, to include a greater
l ength of lymphatic vessels in their drainage direction.
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The deep fascia was never excised, except for the amputation
cases, not even in one patient who was submitted to an integumentectomy
for recurrence of a primary lesion on the leg.
4. Prophylactic lymph node dissection : A block dissection of the neck
was performed in 1,2% (n=6), of the axilla in 1,80 (n=9) and of the groin
in 65,% (n=33), and the decision taken as would retrospectively appear,
on the histology report results : level of invasion III1V and V and/or
tumour thickness greater than 1,5mm. All specimens, but two, were
reported free of metastatic involvement.
5. Local recurrence : The incidence of local recurrence has been
calculated on the subset of 163 patients as defined above (one was a
stage III melanoma at the time of the first consultation = 164).
Recurrence took place in 11 cases (6,7%) despite complete excisions.
RECURRENCE IN RELATION TO PRIMARY TUMOUR
When examined in relation to the primary tumour characteristics, the
following appear : (Table V)
RECURRENCE 
Type Number of Percentage 
Patients/Total % (% of Total) 
Nod 7 / 74 9,5 (64)
SS 2 / 65 3 (18)
LM 1 / 17 6 ( 9)
Amel 1 / 6 16 ( 9)
Acral 0 / 1 0 ( 0)
Level of Invasion
1 / 59 1,7 ( 9)
IV 8 / 87 9,2 (72)
V 2 / 18 11 (18)
RECURRENCE (cont)
Number of patients Percentage 
Tumour Thickness (in mm)
Mean 2,6
Range 1,33 - 4,58
Ulceration 4 36
TABLE V TUMOUR CHARACTERISTICS AND RECURRENCE 
The nodular type of melanoma is accounted for in 64% of total
l ocal recurrences in association with 72% of level IV depth of invasion.
RECURRENCE VERSUS CLEARANCE MARGINS 
Table VI outlines the incidence of local recurrence in relation
to the clearance margins of excision.
Marain No.of patients Local Recurrences 	%
in cm) (total 163) Number
<1 13 2 / 13 1 8
1 17 1 / 17 9
2 18 0 / 18 0
3 38 3 / 38 8
4 44 3 / 44 6,8
5 25 1 / 25 4
>5 8 1 / 8 12,5
TABLE VI CLEARANCE MARGIN AND RECURRENCE 
Except for the subset of patients who had a clearance margin
less than lcm, there is no significant difference in the rate of re-
currence when the clearance margin exceeds lcm.
SURGICAL  TREATMENT : STAGE Ila AND Ilb MELANOMAS 
Only five patients presented with a stage Ila melanoma when
first reporting for treatment (2,4%) and all had wide excision of the
primary lesion with clearance of regional lymph nodes. No dissection
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in continuity was undertaken. One patient refused a block dissection.
Three patients presented two enlarged nodes, one fifteen nodes and one
a simple node; all presented metastatic deposits on histological
sections; however, out of the fifteen clinically enlarged lymph nodes
that one patient presented, only six showed involvement.
Twenty seven patients (13%) who received treatment for a
Stage I melanoma and were clinically and histologically clear of tumour
subsequently developed regional metastases; the delay between primary
treatment and onset of regional involvement varied between 3 and 36
months with an average of 15 months.
The surgical treatment consisted of regional lymph nodes
clearance; no dissection "in continuity" was performed. In an
attempt to determine the parameters of the primary lesion which could
explain the occurence of regional metastases, stage Ilb patients were
screened regarding the characteristics of the primary tumour : level
of invasion and tumour thickness when available, histological type of
the primary lesion, presence or absence of ulceration, and anatomical
distribution. The findings are summarized in Table VII.
The nodular type of melanoma was responsible in 18 cases,
with a Level IV of invasion thirteen times, a Level V three times,
Level II and III only once, with corresponding tumour thickness values
ranging from 1,3mm to 5.1mm. Ulceration was present in only 9 cases
and does not seem to bear any significance, nor do anatomic sites, the
respective number of which are consonant with the overall anatomic site
distribution.
Thus it would seem that three parameters pertaining to the
primary lesion are of significance in the onset of regional metastases,
namely the type of the tumour and the level of invasion and tumour
thickness.










IV 3,1 nod 0 back 0
V 3,8 nod 0 LL 0
111 nod 0 LL 0
IV 2,5 nod 0 UL 0
V - acral + L 0
IV 4,56 nod + LL 0
fV - nod 0 UL 0
1,3 nod + back 0
iIi - nod 0 HN 0
IV 1,4 nod 0 HN 0
IV nod 0 LL +
fl - acral + LL 0
3,4 nod 0 chest 0
II i 2,3 SS 0 HN 0
IV nod 0 chest 0
' 3 nod + chest 0
iV nod 0 UL 0
Iii 1,9 SS 0 LL 0
SS 0 LL 0
I V nod + UL 0
IV LM 0 HN 0
V 6,1 nod 0 UL 0
IV 2,7 amel back 0
iV 1,8 SS abd 0
IV 2,2 nod 0 LL 0
ill 2,1 LM 0 UL 0
TABLE VII METASTASES AND TUMOUR CHARACTERISTICS
HN = Head & Neck : UL = Upper Limb : LL = Lower Limb : Abd. = Abdomen
STAGE 111 MELANOMA 
Of the 32 patients who were treated for a stage II melanoma,
21 developed generalized metastases. Eight stage I melanoma patients
likewise developed generalized metastases without at any stage showing
signs of regional lymph node involvement. Only one patient in the
whole series presented with a stage yl melanoma at the time of first
consultation.
The sites of metastatic deposits are summarized in Table VIII.
It is of interest to mention that two patients who developed extensive
regional metastases had had a prophylactic lymph node dissection.
The histologic type of tumour of the eight stage I patients
who developed metastases was nodular in six cases, lentigo maligna
melanoma and superficial spreading in the two other cases, with levels
of invasion IV and V, tumour thickness between 2,6 and 4,6mm The
delay between excision of the primary lesion and occurence of
metastatic deposits varied between 58 and 6 months (mean 33).
The tumour characteristics of stage lib patients who
subsequently developed generalized metastases are summarized in
Table IX.
RECURRENCE AND SURVIVAL
Recurrence and survival in relation to surgical treatment
alone were examined on a population of 113 patients, 51 of the 164
were excluded since they received medical treatment after surgery.
Their survival will be studied separately. Five year survival was
computed according to Kaplan and Meier's method which allows for
inclusion, in calculation, of incomplete data. (28)
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Brain Liver Lung 	Bone Intestine 	Skin Lymph-nodes
+
5 4 12 6 2 17 15 TOTAL
TABLE VIII LOCALIZATION OF METASTASES
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Level of Tumour ProphylacticType Ulceration Site
invasion thickness +IN dissection
IV - nod + HN +
IV 3,1 nod 0 Back 0
V 3,8 noc: 0 LL 0
IV - nod 0 LL 0
IV 2,6 nod 0 UL 0
V - acral + LL 0
IV - nod 0 UL 0
II 1,3 nod + Back 0
IV 1,4 nod 0 HN 0
IV - nod 0 LL +
V acral + LL 0
IV 3,4 nod 0 Chest 0
III 2,3 SS 0 HN 0
III 1,9 SS 0 LL 0
IV nod + UL 0
IV - LM 0 HN 0
V 6,1 nod 0 UL 0
IV 2,7 amel + Back 0
Iv 1,8 SS + Abd 0
III 2,1 LM 0 UL 0
IV 4,56 nod + LL 0
TABLE IX METASTASES AND TUMOUR CHARACTERISTICS
RECURRENCE AND SURVIVAL IN STAGE I PATIENTS 
Recurrence of the disease occured in 31 cases (29%) in less
than two years after treatment of the primary lesion, and the total
number of recurrences at five years amounted to 35 patients (33%). Of
these, 27 presented regional lymph node involvement and became Stage Ilb,
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8 developed generalized metastases, without at any time showing signs
of regional lymph node involvement and therefore became Stage III
patients.
At two years, 26 patients had died, five are still alive,
four free of disease, one with disease. At five years, 27 patients
had died.
Their results are summarized in Table X and Fig. XII.
No. of Stage I Recurrence at Survival Recurrence Survival 
patients 2 years at 2 yrs at 5 yrs at 5 yrs 
n. n. n. n.
107 31/107 29 81/107 76 35/107 33 80/107 75
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FIG. XII STAGE I SURVIVAL
STRATIFICATION ACCORDING TO RISK 
When trying to predict the outcome of the patients by using
either Clark's Classification or tumour thickness, it was found that
neither technique could be relied upon. As showed in the chapter
devoted to epidemiology, there is a wide dispersion of results when
matching the two methods, particularly when dealing with Clark's Level
III and IV invasion where great overlap is observed between the thickest
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level III melenomas and the thinnest level IV lesions.
In an attempt to introduce more accuracy and to determine which
patients were most at risk and would therefore benefit from additional
therapy, a classification based on the parameters considered to be
determinant in the behaviour of the disease, is proposed; the character-
istics concerned are: l evel of invasion, tumour thickness and growth
pattern, the combination of which leading to a three level stratification;
the accuracy of this classification will be improved further when
individuals's reactions to immunotherapy are introduced. The three
l evels are defined as follows:
Low Risk : tumour thickness less than 0,76mm and Clark
Level I or II in either a l entigo maligna or a superficial spreading
type.
Moderate Risk : tumour thickness less than 0,76mm and
Clark level II in a nodular type, or tumour thickness between 0,76
and 2mm but Clark Level III or it IV in all but the nodular type.
High Risk : tumour thickness between 0,76 and 2mm, Clark
Level III in a nodular type and tumour thickness greater than 2mm,
Clark Level IV or V irrespective of the growth pattern.
The decision to adopt 2mm as a borderline between low and
moderate risk groups was not taken arbitrarily. Several authors (19,
29,30) have adopted different measurements to define high risk patients,
varying between 1,5 to 3mm, but they were considering tumour thickness
as the only parameter useful in predicting survival. The same
measurements were tried when the proposed classification was drafted,
and it was found that the 2mm thickness value gave the most "clear-cut"
results. Likewise, it was considered important to include the type of
the tumour as a decisive parameter and to differentiate the nodular type
from others, since it was found through this survey that it readily gives
rise to local recurrences and metastases, whether regional or visceral,
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irrespective of level of invasion or tumour thickness. Drzewiecki
reported no difference in electronmicroscopy in cell structures
amongst the different types of melanoma (31) and it is likely that the
ability of the tumour to give in-transit metastases early is in direct
relation to the speed at which the tumour grows, which also implies
poor immune response.
Survival was markedly different for each such groups.
(Table XI).
Risk Group No. of Reccurrences Deaths
Patients No. % No. %
Low 28 1/28 3,5 0/28 0
Moderate 36 13/36 36 8/36 22
High 43 21/43 49 1 9/43 44
Total 107 35 27
TABLE XI RISK AND SURVIVAL 
Of the seven patients who presented a recurrence, but are
alive at five years without disease, one was entered in the low risk
group and six in the moderate risk group. The patient alive at five
years with disease had been classified as a high risk patient.
Forty eight stage I patients had a prophylactic regional lymph-
adenectomy; they were retrospectively classified as moderate risk
(n=20) and high risk (n=28) melanomas. Survival at five years for
this subset is summarized in Table XII,
Risk Group No. of Recurrences Deaths 
Patients 	No. % No.
Low 0 0 0 0/0 0
Moderate 20 7/20 35 4/20 20
High 28 13/28 46 10/28 36
Total 48 20 1 4
TABLE XII RISK, LYMPH NODE DISSECTION AND SURVIVAL 
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Survival was not improved by lymphadenectomy. (As mentioned
earlier, two of these patients developed extensive regional cutaneous
metastases),
STAGES II AND III SURVIVAL 
Thirty two patients (28%) were treated for Stage II melanoma
(5 Stage Ila and 27 Stage 11b)1 at five years, nineteen had died (59%),
eight are alive with disease, five are alive free of disease. When
survival was related to the number of involved lymph nodes, it appeared
that when more than two nodes were invaded, the prognosis was poor.
(Table XIII).
Number of Number of Dead 
Patients Involved nodes 	No.
4 1 1 25
7 2 3 26,5
1 3 3 9 59
8 3 6 75
32 1 9 59,4 TOTAL
TABLE XIII SURVIVAL AND LYMPH NODE INVOLVEMENT
However small the series, the results correlate with the
findings of others, particularly Balch et al (32).
Stage III patients, as could be expected, had a very poor
prognosis; of thirty (one de novo and 29 as a result of further spread
of the disease) twenty-six are dead and four alive with disease.
These results, both of Stage II and III melanomas emphasize the need
for adjuvant therapy when such stage of the disease has been reached;
but most of all, means to prevent the deterioration from a stage I to
a stage II or III melanomas are needed.
DISCUSSION 
The problem of clearance margins. 	The concept of wide excision margins
as a mandatory treatment of melanoma has recently been criticized and its
48.
value questioned. The first argument against this surgical attitude
proceeds from the awareness that Handley's report (33) related to the
autopsy findings of a case of advanced disease; in fact he said at the
time that he never had the opportunity to deal with a primary lesion;
"No opportunity of investigating the spread of permeation around a
primary focus of melanocytic growth has fallen to me." It is likely
that he was encountering situations which are most unusual nowadays,
except perhaps when dealing with poorly educated population groups.
His approach to this specific problem is akin to Halsted's treatment
of breast cancers : both, in their time, offered what best they could
to treat what we now regard as incurable and inoperable conditions.
Halsted's radical mastectomy is no longer performed today, because
patients are seen at an earlier stage and because survival was not
i mproved by this radical and mutilating surgery.
Handley's observation on lymphatic spread and permeation is
a classical description of intransit metastases with retrograde lymph
flow resulting from lymph node obstruction, as would likewise occur
after a lymphadenectomy. J S Stehlin has been amongst the first authors
to draw attention to the limited value of Handley's concept and to adopt
a critical attitude towards this surgical form of treatment. (34)
Two theories have been proposed to explain the origin and
growth of melanoma, although not proven. According to one, the tumour
results from malignant changes in melanocytes in a given area and the
tumour grows by a simple cell division; in the other, it is postulated
that the tumour arises in several fields of skin and grows not only by
division but also by malignant transformation of adjacent melanocytes
(35). The spread of the lesion, in the latter concept, would occur by
transference of malignant potential from tumour cells to normal
melanocytes (36,37) and metastases could arise through freeing of
particles from tumour cells to the surrounding tissues.
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In support to the second theory, the observation of Cochran(38)
who found junctional changes of melanocytes around superficial spreading
and lentigo maligna types of lesions, of McGovern (39) who stated that
there was a melanoma producing potential to some distance of the lesion
and finally Wong (40) who reported an increase in melanocytes at a
distance of 5 cm from the tumour in 7 out of 12 patients who presented
a cutaneous melanoma.
Yet, whenever a tumour had been completedly excised and re-
excision performed to satisfy the wide resection concept, no foci of
malignant cells were ever round, whether it be in this study or others
(29,30,37,41). Drzewiecki (42) on the contrary, showed that between
lcm to 5cm around the lesion, the density of melanocytes was lower than
in a symmetrical body location when the tumour was of the superficial
spreading type, and that no difference in the number of melanocytes
could be found when dealing with the nodular type; further, the density
of melanocytes in melanoma patients is greater than in normal population
groups. The findings of this study, that beyond a 1cm resection the
incidence of recurrence does now show significant variations, correlate
well with Drzewiecki's study, and other reports have similarly reached
the same conclusions, (30,34,41,43), including Olsen (37) who, although
advocating a 5cm clearance, could not find any rate of recurrence
i mprovement with wide excisions.
Survival depends upon the absence or presence of in-transit
metastases, which are rel4ted to the characteristics of the tumour :
level of invasion, thickness, growth pattern. In-transit metastases
cannot be controlled by increasing the size of resection. Thus,
extensive excisions, which improve neither the rate of recurrence nor
survival but are not void of morbidity and are unsightly, are ill-advised.
It is believed that recurrence following a complete excision is the result
either of poor surgical technique with inconsiderate manipulation of the
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tumour, and therefore excision of melanomas should not be left to in-
experienced surgeons, or the patient's poor immune response : one
cannot control a systemic break-down by a more radical excision.
PROPHYLACTIC REGIONAL LYMPH NODE DISSECTION 
There is controversy concerning prophylactic lymph node
dissection. The proponents of prophylactic lymphadenectomy claim a
10 to 20% survival improvement when such dissection is done routinely
for stage I melanoma (44,45,46,47,48),without apparent impairment of
the host tumour balance since the incidence of recurrence is similar to
that of patients who had no lymphadenectomy. Conversely, some series
show no significant difference in survival between patients treated by
resection alone and those who underwent resection with lymphadenectomy
(23,32,36,37,38,39).
The introduction of Clark's classification and later Breslow's
technique of measuring tumour thickness did not end the controversy.
Some advocate lymphadenectomy for levels II and IV of invasion (49) while
others propose it for levels IV and V lesions (50). Using tumour thickness
as a decisive criterion, controversy exists concerning which measurement is
meaningful : 1,5 min for some (51), less for others (52,53,54,55). As more
parameters are introduced and their interaction considered to reach a
decision as to whether such patients should or not have a prophylactic
l ymph node dissection, the situation becomes even more obscure. (56)
If "routine" or "elective" or "prophylactic" lymph node
dissection was of undeniable value, data would abound to support the
superiority of the results; lack of, or contradictory data rather proves
its ineffectiveness in improving cure rates.
Patients who had a regional lymphadenectomy in the present
series are few in number and no meaningful conclusion can be drawn; the
results show, however, that they did not fare better than patients
treated by excision alone. Thus it is difficult to justify this surgery
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and its morbidity, if improvement remains hypothetical. The same
argument of a systemic break-down of the host's immune sytem, postulated
as a cause for local recurrence, can be applied here too, and so the
conclusion : surgery alone is inadequate in controlling a systemic
disease.
CURABILITY
Some anatomical sites have traditionally been associated with
poor prognosis : trunk, head and neck and extremities, leading to as
extensive resections as possible, associated with regional lymph node
dissection $ and the operative protocol defined in relation to the site
of the tumour (57,58,59). There is no convincing difference in survival
for the various protocols proposed. Again, the parameters of importance
i n predicting the outcome of the disease pertain to the tumour itself
i.e. how advanced the lesion is at the time of presentation, and its
growth pattern; the site of the lesions did appear to bear significance
in survival neither in this series, nor in others (49,60) and there is no
justification for more radical and mutilating surgery according to site.
Clearly, major improvement in survival for melanoma, irrespective of its





Medical treatment, or palliative as often qualified, consisted of
the following :-
Radiotherapy (cobalt)
Chemotherapy (DTIC, CCNU, Vindesine, Oncovin)
Immunotherapy (Bacillus Calmette-Guerin)
Combination of chemotherapy and immunotherapy
Combination of radiotherapy, chemotherapy and immunotherapy.
Immunotherapy, in the form of BCG injections, was only introduced
routinely in the treatment as from 1978; previously chemotherapy and/or
radiotherapy were the only alternatives. BCG is given at a dose of 0.01m1
injected intra-lesionally or around the lesion, or at the site of excision,
at three week intervals; DTIC and CCNU are administered at five or six
week intervals, with a 500 mg dose of DTIC and 200 mg dose of CCNU.
Vindesine and Oncovin are used when the former are not well tolerated.
PATIENTS SELECTION 
Twenty two Black patients started a course of immunotherapy
with chemotherapy. Attendance was so poor and at so irregular intervals
that no meaningful conclusions concerning medical treatment can be drawn
from this group. Transport difficulties and related cost may account
for this state of affairs, but negligence and lack of motivation play a
great role too. A possible answer to the problem would be the use of
oral BCG, that the patient could take home. Good results with this
technique, used in patients presenting an advanced stage of the disease,
in this similar to most of the Black patients, have recently been reported.
(61).
Eighty six White patients have been referred for such treatment
from 1975 to 1982. Prior to 1978, few patients had been referred to the
Oncology Department for palliative therapy, however invasive the tumour
may have been. It appears, rather, that only patients in a near terminal
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stage of the disease qualified for referral.
Thereafter a change of attitude seems to have prevailed,
resulting in more patients receiving medical treatment.
Radiotherapy : this therapy was used for treatment of visceral and/
or bone metastases only.
Chemotherapy : the decision to use chemotherapeutic agents resulted
mostly from exclusion; patients neither too old nor in too poor a
general condition to be given aggressive treatment.
BCG injections, being nearly void of complications, have been ad-
ministered routinely.
The combination of BCG therapy with chemotherapy was
proposed in patients estimated to be at "high risk", namely people who
had had a deeply invading or thick tumour and/or enlarged regional lymph
nodes and/or had visceral metastatic deposits. However, no set
parameters which could be used to select patients in terms of risk had
been clearly defined in treatment selection. (Table I).
Age,
Sex 
mean 54 : range 19 - 80
: M 29









Lower Limb 1 0
Total 47
No metastases 1 6  
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TABLE I PATIENTS CHARACTERISTICS 
The sixteen patients presenting no metastases were referred for
prophylactic treatment, and four of them received a combination of
i mmunotherapy and chemotherapy.
TREATMENT 
SYMPTOMATIC TREATMENT 
Three patients were referred at such an advanced stage of the
disease that symptomatic treatment only could be offered.
Radiotherapy
Two patients had radiotherapy only to lung, brain and bone
metastases and died.
Chemotherapy
Two patients had chemotherapy alone as treatment to lung, bone
and skin metastases for one, and abdominal metastases for the other.
Both died (survival twenty months and six months respectively).
Immunotherapy with and without Chemotherapy 
Forty seven patients received BCG injections, in twenty cases
with chemotherapy. Local irradiation was used on osteolytic lesions and
large metastatic deposits during the course of therapy, when necessary.
SURVIVAL
Survival was studied without using Kaplan and Meier's
statistical method (28) as it could not give meaningful results in the
present situation.
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SURVIVAL AND IMMUNOTHERAPY WITH CHEMOTHERAPY
The summary of patients parameters and results of treatment
appear in Table II. Six patients are alive, free of disease (30%), one
is alive with disease, twelve are dead (60%). Of the six patients alive
free of disease, two are still receiving BCG injections. (Table II :
Survival with combined Immuno-chemotherapy).
SURVIVAL AND IMMUNOTHERAPY 
Patients characteristics and treatment results are summarized
in Table III. Twenty patients are alive free of disease (74%), two are
alive with disease (7,4%) and five patients died (16,5%).
(Table III : Survival with Immunotherapy).
DISCUSSION
The clinical behaviour of melanoma suggests that the disease is
influenced, IF not regulated, by immunological factors. As proof,
the following findings :-
a. Tumour regression, associated with lymphocytic infiltration, which
can be such that the primary lesion may disappear entirely and be
suspected only on the discovery of a depigmented area, whereas the
patient presents with metastases.
b. Reports of transplantation of melanomas in immunosuppressed patients
(62,63).
c. Regression of melanomas after transfusion with whole blood recovered
from melanoma patients who had had a complete remission (64).
d. The finding of high titer of anti-melanoma antibodies in patients
with localized disease or undergoing spontaneous regression, and
titer as low in patients with advanced metastatic disease as found
i n a normal population (65).
Consequently, several agents have been used to enhance the
i mmune system of malignant melanoma patients, either specific (tumour
associated antigens (66) or non-specific : Corynebacterium Parvum and
Type
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Sex Age Ins Level Ulc DFI in Conditions at R
x Response Evolutions Survival in Result
Thick Months beginning of years s months
treatment
M 53 N IV 4 no met I + C No recurrence 4 Alive (FD)
1,6
M 67 N IV 3 no met I • C + No recurrence 3 Alive (FD)
1,92
N 29 N V I Rep.met I + C + Mediastinal metastases 11/12 Death(Chest met.)
4 .3
N 61 N IV I Cut.met I + C Multiple regional cutaneous












M 37 N V • 2 Recurrence(local) I + C
Numerous skin nodules 17/12 Death(skinfibone met.)
1,8
F 34 55 IV 1 Regional lymph
nodes (excised)
nodule In breast
I • C ♦ Developed cutaneous
metastases (excised)
7 Alive (FD)
F 65 Nod IV 1 Occurrence (local)
regional lymph
nodes (excised)
I • C No recurrence 4 Alive (FD)









F 60 Nod IV
4.56
+ 1 Reccurence skin
nodules
I • C Numerous skin nodules 6/12 Death (multiple
skin metastases)
F 80 Nod V
2,6




F 44 Nod IV 2 Skin metastases I • C Skin and bone metastases 1 Death(multiple met.)
F 52 Nod IV 3 Recurrence (local) I + C Devel.lump skinfibrain met. 4 Death(L,S,SB,met.)
F 32 Nod IV 2 No recurrence I • C + No recurrence 2 Alive (FD)
1,09 No metastases
F 54 Nod V • I Multiple abdominal
metastases
I + C Peritoneal metastases 11/12 Death
N 48 Nod II • 1 Regional metastases i • C Multiple skinalump met. 2 Death
1,3 (excised)
M 63 Nod 3,3 Lump metastases I + C Lump metastases Death
F 25 SS IV 3 No recurrence I • C then No recurrence (still on BCG) 3 Alive (FD)
2,2 No metastases I only
N 38 Nod IV 1 Regional metastases I • C then No recurrence (still on BCG) 4 Alive (FO)
1 only
19 Amel IV 1 Regional I + C Ho new lesion 3 Alive (with disease)
TABLE II SURVIVAL WITH COMBINED IMMUND-CHEMOTHERAPY 
OFI : disease free Interval, FD : free of disease, I : Inman-therapy,
C chemotherapy,
56b
Condition at beginning Response to 	Evolution Survival (years) Result
of treatment Treatment 
no met • No recurrence 2 Alive (FD)
Regional L/N No recurrence 4 Alive (ED)
no met + No recurrence 6 Alin. (FD)
no met No recurrence 2 Alive (FD)
no net . No recurrence 3 Alive (FD)
No met. block • No recurrence 3 Alive (F0)
no met + No recurrence 3 Alive (FD)
no net a No recurrence 3 Alive (FD)
No met. block • No recurrence 2 Alive (FD)
Brain met Multiple visceral Died
metastases
Regional L/N block Multiple metastases Died
Regional L/N block Lung metastases I Died
Regional L/N block Visceral metastases 3 Died
Regional L/N block No recurrence 5 Alive (FD)
Regional L/N block No recurrence 3 Alive (FD)
no met No recurrence 3 Alive (FD)
no filet No recurrence 2 Alive (FD)
no met No recurrence 2 Alive (FD)
no met No recurrence 3 Alive (FD)
no met v No recurrence , 5 Alive (F0)
no met No recurrence 3 Alive (F0)
no met + No recurrence 4 Ali ve .(En)
Subcutaneous nodules • One nodule disappeared 3 Alive with diseas
others isq.
Subcutaneous nodules • Stable 5 Alive with diseas
No met. block No recurrence 4 Alive (FD)
no net + No recurrence 3 Alive (FD)
Altaneous metastases + Regional L/N Died





38 Nod I V 0 2
F 3 1	SS III 0 4
1,6






F 76 Nod III 0 3
F 25 55 III + 3
0,9
F 67 N I V + 3
F 70 N Ill 0 2
1,25
F 54 N I V 0 2
1,7
F 80 N V
3,2
5 4 	N V
F 79 SS I V 0 0
2,2
33 N V 2
3
25 N iii 0 1
22 N IV 0 0
3
30 N I V 0 0
3
H 50 5$ Iii 0 0
0,4
68 N V 0 0
2,8
19 Amel 111 0 0
67 Ac 1‘, 0
49 55 I V 0
1,6
M 19 N III 0 0
M 70 LM IV +
2,1
M 33 N V +
M 24 N III 0
M 67 N III 0 0
1,92
19 amel IV +
4,2
TABLE III SURVIVAL WITH I MMUNOTHERAPY
FD Free of disease
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Bacillus Clamette-Guerin, or both (67). BCG, of all agents, Is the
easiest to use and the most readily available.
There is controversy concerning the value of BCG immunotherapy,
variably described as high, as an improvement or simply disappointing.
It is likley that different sets of patients have been considered.
Should a patient lack immuno-competence, or present either a large
tumour or disseminated metastatic deposits, little can be expected in
terms of survival. To test patients' immuno-competence, a study of
delayed cutaneous hypersensitivity to DNCB has been advocacted prior
to initiating treatment (68). No such tests were performed in the
present study; however, the patients' immune response could be
appreciated by the intensity of reactions occurring at the site of
injection and regional lymph nodes enlargement. Lack of reaction
i mplied a doubtful beneficial effect.
Since a positive reaction BCG injections proved to be so
i mportant, it was retrospectively considered as a fourth parameter to
determine risk categories, and survival of stage I patients who had
received immunotherapy and immunotherapy with chemotherapy was accord-







Number of Response to Death 
Patients BCG therapy 
No. % No. %
2 +( 2) 1 00 0 0
3 +( 2) 67 0 0
-( 1) 33 0 0
17 +(13) 76 1 6
- ( 4) 23,5 2 1 2
22 (+):17 ( - ):5 3
TABLE IV RISK, IMMUNE RESPONSE AND SURVIVAL 
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Low and moderate risk patients did well, which was predictable.
In high risk patients, 76% showed a positive response to BCG - immuno-
therapy and only one died, the remaining are free of disease. Of the
four patients who did not present such response, two died and two are
alive with disease.
The series is allegedly small, but allows to conclude that
signs of immune response to BCG bear favourable prognosis; more
positive conclusions will be drawn in a few years time when a greater
number of patients are available for analysis.
In stage II and III patients, the results are less favourable,
whether the patients received BCG immunotherapy alone or in conjunction
with chemotherapy. Nine stage II patients responded to immunotherapy,
four died; three patients did not respond, two died. Seven stage III
patients showed a positive response to BCG, three died; four did not
respond and died. I mmunotherapy does not seem to have a positive action
on visceral metastases, irrespective of the patient's response. However,
the group oc patients who have received adjuvant treatment after surgery
shows a better overall survival than the group of patients who were
surgically treated only.
As a result of these findings, it can be said that lack of
response of the host's immune system to BCG aggravates the prognosis,
while a positive response, mainly in stage I patients allows for
optimism. Since BCG immunotherapy is nearly void of morbidity, there
is no reason why all stage I patients, irrespective of their risk group,
should be deprived of the benefits of this therapy. Yet the question
remains as to how long such treatment should be continued; would lack of
response be an incentive to persevere, or a reason to abandon? Could
it be that, after some time (which would have to be defined), the
efficacy of the treatment would decline and if so, would a rebound
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effect take place? If this were the case, what then would be the
optimal duration of the therapy? Answers to these questions can
derive only from a survey extending over many years for as many
patients as possible; they are an incentive to further studies.
REFLECTIONS UPON THE AETIOLOGY OF CUTANEOUS MELANOMA
- A NEW HYPOTHESIS -
6 1.
BACKGROUND
LIGHT  AND LIFE
Solar light and water are the two main components of our
biosphere and light the only spring of energy of the system; it is
responsible for terrestrial life as well as the origin of life (69,70).
Organism must be sensitive to such energy if they are to use the sun to
maintain life and to survive, but this implies the possibility of
overdose; for example, DNA can be damaged by solar radiation and
therefore some form of control is needed. Sensitivity also implies
the creation and transfer of information. Living organisms develop
means to see and de-limit a band of the spectrum as "light". They
identify subjects of vital interest - food, mates, predators - through
reflected light; they modify their own reflectance by appropriate
colouring to improve their chance of avoiding predators or catching
preys (71). Lastly a fraction of available light is suitable and used
for chemical work; animals have come to synthetize vitamin D from
precursors with energy from ultra-violet light.
Natural ultra-violet presents three wave-lengths with
different sections: UVa (320 - 400 pm) held to be inocuous and
responsible for tanning; UVb (280 - 320 km) responsible for erythema
and burning and UVc (200 - 280 pm), absorbed by the ozone layer, highly
energetic and therefore dangerous. Natural UV radiation is greatly
enhanced by white surfaces : sand, snow,light building and water. Its
skin absorption is increased by moisture. (McCarthy).
The pigmentation of vertebrates results mostly from the
production of melanin by melanocytes, specialized cells derived from
the neural crest. Melanin is the end product of complex reactions,
starting with tyrosine and ending into polymerisation of indol-quinone;
i t is then linked to proteins to form a melanoprotein. The melanocytes
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are able to expand and contract to produce colour changes, are located
in the basal layer of the skin and are responsible for pigmentation
whether it be a racial characteristic of the result of increased solar
exposure (72).
Meianocyte activity is controlled by the system melanocyte-
stimulating hormone (MSH) / melatonin in response to light levels, via
the hypothalamus, High levels induce production of MSH, whereas low
l evels trigger the production of melatonin. In albino patients, the
l evels of melatonin are 10 to 15 higher than in normally pigmented
persons (73).
As MSH is secreted at the same time as ACTH, and since they
share a short same sequence of amino-acids, it is likely that melanocyte
activity is in fact under the control of both hormones (74).
It must be noted that very little research on MSH and its
action has been carried out, and information is very scanty.
LIGHT AND VITAMIN D
It has been assumed that the pallor of White people is a
means to provide for adequate systhesis of vitamin D under the climatic
conditions of North West Europe (75). The actual problem of rickets
among the Non-White immigrants in the United Kingdom tends to support
this view (67). However, like most broad generalizations, to explain
the light skin colour of Europeans through their need for vitamin D
present some difficulties : should this be the explanation, the White
population of South Africa would indeed show a high incidence of excess
production of vitamin D, a highly toxic substance, and lethal calcif-
ications, unless there was a feed-back mechanism between blood levels
of vitamin D and melanin production.
In so far, there is no proof that such mechanism exists. It
is true that there is a high incidence of rickets among the Black
population of South Africa, but this is more likely to be related to
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nutritional problems; and what could be the advantage of being Black
to a person living in the tropics since heat reflectance is thus grossly
i mpaired?
But whatever the reason for the lack of pigmentation of the
European, the price paid is the accumulation of actinic damage to the
skin and the high incidence of basal cell and squamous cell carcinomas
of the skin.
MELANOMAS AND OTHER SKIN CANCERS 
Melanocytes can undergo malignant changes and produce melanomas
which may occur on any part of the body where melanocytes exist, that is
to say not only skin but also mcosa, as found in the nasal cavity as well
as the vagina. Melanomas are much less common than basal cell or
squamous cell carcinomas.
Basal cell carcinomas are not rare on areas usually protected
from direct sunlight, and so are squamous cell carcinomas. Basal cell
carcinomas are exceedingly rare in Negro population groups, squamous
cell carcinomas less so. Most of the latter appearing on unusual sites,
irrespective of the population group, result from intercurrent factors
such as burn or irradiation. The distribution of neither basal cell
carcinomas nor malignant melanomas fits adequately the distribution of
sunlight and shade.
The Ozone la yer problem: Malignant melanoma is of particular
interest for the following reasons : its incidence is increasing amongst
population of Northern European descent with an increasing death rate,
and amongst the Zulu population too.
Secondly, the incidence of melanoma has been linked to
exposure of Europeans to sunlight. This is a matter of much contro-
versy, as will be discussed below. These issues result from the deep
concern that human activities are introducing changes to earth's upper
atmosphere.
64.
As sunlight reaches the outer layer of earth's atmosphere,
oxygen molecules are being re-arranged as ozone (0 3 ). Ozone absorbs
radiations from abour 310 pm wave length and is opaque at 296 pm. As
a result, life on earth is shielded from a considerable amount of UV
radiations and has evolved under these conditions ever since oxygen
appeared. Ozone concentration at ground level varies proportionally
to the intensity of UV radiations and varies from 15 ppb in heavily
i rradiated desertic zones to 50 ppb at 3000 M altitude and reaches
a maximum between 18 and 35 km. In cities presenting high levels of
pollution, the ozone concentration reaches 1 ppm and more. Conversely,
there had been fears that the ozone concentration of the upper atmosphere
would decrease, as a result of supersonic aircraft exhaust gases (77).
It would now appear that such fears were unjustified (78),
although satellite observation suggests that the thickness of ozone layer
is becoming thinner (79). What can be ascertained however, is that
changes have been minimal, and that changes of UV flux at ground level
cannot account for the increasing incidence of melanoma.
As with many cancers, no animal model allows for experimental
production of melanoma, depriving us of insight as to its aetiology.
Although transfers of naturally occurring melanomas to experimental
models have been successful, and repeated exposure to carcinogens
have induced melanomas, only recently haye experimentally created
tumours shown resemblance to the human disease (80). No experimental
system, in so far, has allowed for reproducible induction of melanoma
through UV irradiation, and there can only be speculations regarding
the shield effect of the ozone layer and its changes, which effect
only a narrow band of the spectrum below 310 pm. There are reasons,
but no proof, that erythema in man, carcinogenesis in mice, DNA absorp-
tion spectrum, should be in this range.
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Despite these uncertainties, the question yet must be addressed
as to whether UV-b is a limiting factor for the incidence of melanoma
of the skin, and if it is, what is the quantitative relationship
between increased intensity and increased incidence of melanoma.
RISK AND PHYSICAL CHARACTERISTICS 
SKIN PIGMENTATION 
Since the report of Rudolph Matas in 1896 on "The surgical
peculiarities of the Negro" it has been accepted that dark skinned
persons were at reduced-risk of developing melanomas. All the authors
reporting on this affection in Africans emphasize the low overall
incidence rate (10,15,80,81,82) but stress the high incidence of melanoma
of the sole of the foot, whether living in America or Africa.
Variations from community to community are minimal, and the
occurrence of the tumour at such site bears no relation to sunlight
exposure.
Similarly, Blacks present lower rates for ocular melanomas
as compared to Whites, as well as lower rates for internal cavities.
This implies that there is more to the problem of pigmentation than
melanin acting as a "sun screen". Rates of malignant melanomas in
European population groups show great variations, whether still re-
siding in their country of origin or abroad. Despite living under the
highest latitudes, people of Scandinavia show a very high rate of
incidence (but not the Icelandic Group , which benefits'in summer of
uninterrupted solar exposure) (83,84); despite high medical standards,
death rates are also high. Death rates from Scotland and Ireland are
l ow, yet in Australia people from Irish descent present higher rates
than their British Isles fellowmen (85,86).
Population groups from Mediterranean countries or from such
origins show a very low incidence and low mortality rate, however
served by a lesser medical service; such findings do not correlate
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with a latitude reversal effect.
MOLES AND PRECURSOR LESIONS 
In the eighteen century in Europe and mostly in France, moles
were regarded as "beauty marks". Indeed, if ladies were unfortunate
enough to be deprived of such marks, they would readily use black plasters
of various shapes in various locations as a palliative measure.
Traditionally, malignant melanomas have been associated with
naevi, although the closeness of the relationship is not always easy to
define at the time of histologic examination, since often there has
already been destruction of the initial lesion.
Allen and Spitz (87) state that, with few exceptions, melanomas
arise in junctional or compound naevi. For Lennox (88), l ess than
500 of melanomas arise in previously existing naevi, less than 25%
according to Becker (89).
Hewer (90), studying melanomas in Sudanese Negroes, disregards
any relation with pigmentation but relates the high incidence of foot
l esions to trauma.
Pack (91) found that naevi were uncommon in pigmented races
and Heselson (92) presented the following results of a survey of moles
and melanomas in South Africa.
Melanoma Moles
2 to 1 (Head and Neck)
30 to 1 (Genitalia)
50 to 1 (Sole Foot)
The lesser pigmented skin and mucous membranes in Negroes
presents with naevi and lentigenes. According to A J J Emmet and
M C E O'Rourke (43) "naevi on the palms, soles, genitalia and mucous
membranes are said to be junctional, but many are compound naevi.
Junctional naevi occur anytime after birth; their great importance lies
in the fact that they may develop into a malignant melanoma."
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Lewis (93) showed that there is a close relationship between the
i ncidence of naevi and the incidence of malignant melanomas of the
sole of the foot. If such a relationship does exist, similarities
in incidence rates must appear for other sites and be linked to sex
and age. There is no record, however, of such a survey having been
carried out in the past and it was decided to conduct such a study.
MELANOCYTIC NAEVI SURVEY (Bantus) 
MATERIAL AND METHOD 
Four hundred patients, 200 males and 200 females were asked
to participate in the survey; all presented with dark brown or black
skin and were attending the Plastic Surgery Clinic for unrelated
affections. Patients presenting burns or burn scars, degloving
injuries, crush injuries to hands or feet and lip bites, were excluded.
The diagnosis of melanoctyic naevus was made on clinical
grounds and defined as a well circumscribed pigmented papular lesion.
Mottled areas were excluded. On six occasions, in-patients (burn
cases) agreed to having biopsies taken from what was defined clinically
as melanoctyic naevus, to confirm the diagnosis for the whole survey;
two biopsies were taken from the plantar skin, volar skin and muco-
cutaneous junction of the lip respectively; one biopsy from the sole
of the foot showed signs of junctional activity and every lesion was
histologically described as a naevus.
RESULTS
The lesions were recorded according to the following sites
and sub-sites. Head and neck, lip, upper limb, fingers and volar
skin, trunk, lower limb, toes and plantar skin, as well as age and
sex.
Thirty patients (7,5%) presented no lesions, 17 males and
1 3 females. Of the 17 males, 15 were in the 0 - 10 age group, 1 in






were in the 0 - 10 age group, one in the 40 - 50 age group.
The average number of melanocytic naevi was 9,94 per patient
with a total number of 3680 lesions, 2208 for the female group, 1472
for the male group. (ratio 1,5 : 1)










Limb Plantar skin  
5,2 4,1 4,4 17,3 28 3 38
TABLE I SITE RELATED INCIDENCE 
There was no significant differences in sex/site related
incidence. The sex/age related incidence is shown in Fig. II. The
sharp rise in incidence at puberty is followed by a gradual decline
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FIG. II SEX/AGE RELATED INCIDENCE 
Naevi appear in significant number at the time of puberty, and
in each age groups, females presented more lesions than males.
DISCUSSION
The average of 9,9 lesions per patient correlates well with
Lewis'findings in Uganda (11/patients) but not with Pack's figures of
3 per person in the South African Bantu (89) - similarly, the finding
of 92,5% of persons with naevi is in accordance with both Lewis' and
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Hewer's reports (88,91).
The high incidence of melanocytic naevi of the plantar skin,
nearly always on pressure areas, volar skin and mucosa, in contrast to
the low incidence of these lesions in pigmented skin, correlates well
with the incidence of melanomas in Negroes in these subsites and the
rarity of tumours arising in pigmented skin. (Table II)
Head/ 1 ; Upper Fingers Lower Toes 
Neck "'P s 	Limb Volar Trunk Limb Plantar 
Skin Skin 
Melanocytic
5,2 4,1 4,4 17,3 28 3 38
Naevi (%)
Melanoma GO 0 2,04 0 1 7,3 0 4,08 76,5
TABLE II MELANOCYTIC NAEVI AND MELANOMAS
MELANOCYTIC NAEVI SURVEY (WHITES) 
MATERIAL AND METHOD 
The same study was extended to the White population group, as
Sagebiel reported that in a series of early malignant melanomas, histologic
evidence of pre-existing naevi could be identified (94); again no
record could be found of a study examining the relationship of naevi
and melanomas by site and sex. Four hundred patients attending the
Plastic Surgery clinic for unrelated complaints participated in the
survey, equally divided into males and females, with the same exclusions
as for Black patients.
RESULTS
Of the four hundred persons, 23 had no apparent lesion, all
of them in the 0 - 10 age group. The mean number of lesion was found
to be 15,2 per patient, with a maximum of 34 in one female patient.
Since melanomas in Whites occur in different sites than in
Negroes, the sites and subsites were defined as : head and neck, upper
back, chest, lower back, abdomen, upper limb, lower limb. The results










Head Upper LowerBack Chest Abdomen 
Neck Limb Limb
Males 7 12 5 4
Females 4 7 3 3
11 9
16 15
TABLE III MELANOCYTIC NAEVI AND SITES
The age and sex related incidence is represented in Fig.III.
The sharp rise in incidence at puberty is followed by a gradual decline
and the histograms for males and females are very similar. As with
Black patients, there is a higher incidence of melanoma in sites
which present the more melanocytic naevi.
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FIG. III SEX/AGE RELATED INCIDENCE 
MELANOCYTES 
A study of the skin in 50 specimens examined for basal cell or
squamous cell carcinomas, (therefore from skin exposed to UV radiations)
and regarded as clinically normal and histologically free of tumour,
showed that the number of melanocytes in the basal layer decreases with
age; however, since these cancers are associated with actinic damage to
the skin, the material may not be representative. Yet, a recent study
of normal skin biopsies tend to confirm this finding (95).
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Drzewiecki (42), studying normal skin in malignant melanoma
patients showed that the overall melanocyte population in such patients
is greater than in a non-affected person, and that often there were
more melanocytes in the normal skin than in the direct vicinity of the
l esion; this finding could be related to a host immune reaction.
Recently a syndrome of familial malignant melanoma, variously
reported as "familial atypical multiple mole melanoma syndrome" (96),
"dysplastic naevus syndrome" (97) or "BK mole syndrome" (from the
family names of two sets of patients) has been recognized and is
associated with abnormal naevi, both clinically and histologically.
Its recognition is of importance for studies of the pathogenesis of
malignant melanoma and clinical prophylaxis, whenever possible, for
the families. It was recognized however, that such syndrome can
occur sporadically, and it is of great interest to know that melanomas
can arise from naevi when patients have to be immuno-suppressed (98).
REACTION TO EXPOSURE 
The physical characteristics of melanoma patients compared to
non-affected persons have not been very actively investigated, the main
reasons being the great size of population groups required, sophistication
and therefore cost.
Three studies in White population groups from Australia (99),
New York (100) and Norway (101) show some degree of unanimity. For
L ancaster and Nelson (99): "Those who produce little pigment in the
skin are more prone to melanoma than those who produce pigment readily,
and that sunlight appears to be as important in the production of
melanoma of the skin as it is in the production of basal cell
carcinoma and other skin cancers."
Gellin (100) stated that .. "There is a tendency for patients
with malignant melanoma to have light complexions, light eyes, blond or
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red hair and to spend a greater amound of time outdoors, when compared
with the control group. There is a close correlation of findings in
these respects with our previously reported study of patients with
basal cell epithelioma."
Kleppo and Magnus (101) reported that .."highly significant
differences were demonstrated as regards the tolerance of sun exposure
and propensity to freckling. The melanoma patients tolerated sun
exposure less well and freckled more easily than the controls."
It is likely that these groups of investigators happened to
find the same systemic difference between their melanoma patients and
control groups although they did not deal with large numbers, and did
not use statistical methods which could handle interactions. A recent
case-control study shows, however, that there is excess of freckling in
melanoma patients (102). More recently an attempt has been made to
relate the reaction to light exposure of melanoma patients in a systemic
way, classifying the skin in four types (103,104):
Always burn Never tan
Always burn Sometimes tan
Sometimes burns Always tan
IV Never burns Always tan
This classification was retrospectively applied to 200 white
patients of the present series, after personal interviews 1 with the
following results :
Type I : 13%, Type II : 14,3%, Type III : 65,5%, Type IV : 7,2%.
It has been found (94) that in melanoma patients, erythema
produced by a dose of 300 pm radiation eight times the individual's
minimal erythema dose persisted for two weeks in 85% of cases, compared
with 34% in controls and 92% in non-melanoma skin cancer patients.
It was found also that the number of UVc induced sister
chromatid exchanges in peripheral leucocytes of melanoma patients was
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higher than in normal controls.
An interesting hypothesis, unfortunately refuted by actual
studies, is that melanoma patients have the same difficulty in DNA repair
as Xeroderma pigmentosum patients.
GENETIC BACKGROUND 
There is evidence of familial predisposition to malignant
melanoma. There has been no comparative study, however, to clarify
whether such familial aggregation varies in intensity with incidence.
This could work either way :- an adverse environment could induce
numerous cases at random, or could selectively produce tumours in
families where such predisposition exists. Unfortunately the present
series could not be used to further investigate this hypothesis. It
can be concluded however, that genetic predisposition could work through
skin colour or through factors which do not show visible expression
but produce the familial aggregation of cases. We can reasonably pre-
sume that reactivity of the skin to sun exposure, irrespective of the
pigmentation, is under genetic control. Furthermore, genetic factors
must influence the development of melanocytic naevi as well as
dysplastic naevi.
OCCURRENCE 
In White patients, the age at which lesions of the trunk and
limbs are diagnosed is markedly lower than for head and neck tumours,
whereas there is no such difference in Black patients. Yet, these
anatomic sites get less sun exposure.
Increases in long term risks between successive birth cohorts
will reduce the increase with age observed in a set of age-specific
rates derived from a single time period (102). When this effect is
accounted for, the increase with age of cutaneous malignant melanoma is
no different from other cancers such as those of stomach or colon(105).
The influence of age on the incidence of melanoma is in
itself surprising since both the number of melanocytes in the germinal
l ayer of the skin and the number of naevi decrease with age. It would
rather be expected that melanomas, melanocytes and naevi would decrease
in the same way.
A consensus of opinion has emerged that melanomas during
pregnancy carry a poorer prognosis than in non-pregnant patients
(106,107). Since there was no such case in our series, no opinion
can be given. In order to obtain valuable data regarding this
problem, a great number of cases is necessary and such a survey
should be conducted on a national level.
ANATOMIC SITE DISTRIBUTION
As far back as the 1930's, there has been great interest in
Australia about melanomas. Lancaster (108) reported in 1956
"Dr A G G Cooper of the Queensland Radium Institute, Brisbane, has
believed for some years that sunlight is an important predisposing
factor in melanoma, and that melanoma is more common in the northern
parts of Queensland than in the southern, which is also true for rodent
ulcers, and epithelioma".
As early as 1931, malignant melanoma was distinguished from
other skin cancers in Australian statistics, which led to the findings
that there happened to be excess incidence on the female lower limb
(109), and that sunlight, pregnancy and trauma were playing a part in
the occurrence of the tumour. Lancaster and Nelson (99) commented on
anatomic sites : "It might have been expected, in view of the findings
concerning the aetiological importance of skin characteristics, that,
depending on the area of skin exposed, the site of the melanoma would
be affected. This effect is not apparent." Petersen et al (110)
showed that the high incidence of melanomas of the lower limb in females
(Europeans) was due to extra tumours between knee and ankle and stressed
714.
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the role of exposure. The corresponding area of high incidence in
moles in an area of differentially exposed skin is the external ear.
Squamous cell and basal cell carcinomas are more concentrated
on exposed skin than are superficial spreading and nodular melanomas.
If melanomas result from skin exposure through changes in clothing
fashion, one way to prove this assumption would be to divide the skin
in very small areas and see how such a cohort would fare over the years.
LATITUDE GRADIENTS 
Until the sixth revision of the International statistical class-
ification of Diseases and Causes of Death, melanomas, squamous cell and
basal cell carcinomas had been grouped together. Following this revision,
melanomas were separately classified and in 1956 Lancaster (108) published
an analysis of the influence of latitude of residence on the death rate,
from malignant melanomas of the skin in White population.
The broad latitude gradients that Lancaster found in White
populations have been confirmed in smaller and more homogeneous pop-
ulation groups; there is north-south gradient in mortality in North
America (111), England and Wales (112), Norway (113) and Sweden (114),
Finland (115) and a South-North gradient in Australia (116). However,
as was indicated by Lancaster in his initial study, there are dis-
crepancies : the figures he quoted for South Africa show that mortality
was higher in the Cape and Natal Provinces than in the Transvaal and
Orange Free State, but a recent survey (15) shows different figures.
No gradient could be identified in the Natal Province among the White
population but this is too small a population group for significant
conclusions to be drawn.
The discrepancies regarding latitude gradients and mortality
rates derive from three sets of observations : unexpected normal rates
among White persons living in a tropical environment; paradoxical
latitude gradients associated with varying degrees of pigmentation;
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gradations towards urban residence and economic status. It has been
shown recently (117) that malignant melanoma rates were no different
in Southern or Northern Queensland, nor in North Western or Southern
Australia (118). Two explanations have been proposed : either this
denotes a low dose - response curve to a given dose of radiation, or
the propensity of Whites living in the tropics to protect themselves
more than those living further from the equator. From Queensland again,
there is evidence that basal cell carcinomas present to a lesser degree,
the same discrepancies as melanomas. Therefore the effect, whatever
its cause, may not be specific to melanomas.
Mediterranean people have low incidence and mortality rates,
whether resident in the old or new world, while Scandinavians present
high rates despite living markedly further from the equator; but
although belonging to the same ethnic group and living under the same
conditions, Icelandics have very low rates. This finding invalidates
the explanation that Scandinavians pay a higher price because of their
adaptation to their particular environment.
Because UVb is a part of the spectrum where changes in strato-
spheric ozone would act and because of experimental action (DNA absorption,
cancer induction in experimental animals) a major question is the
relationship of melanoma incidence to UVb. Measuring the flux of UV
light over several years in 18 countries in the USA., Baker-Blocker
(119) could not find any such relationship.
IMMIGRANTS 
After adjustment for age had been made, it was found that
duration of residence in Israel was a major factor in melanoma risk
in persons of European origins (120).
These findings maybe biased by the fact that the highest
incidence was found in people living in Kibbutzim and it is possible
that the earliest immigrants were concentrated in these Kibbutzim. A
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differential mortality rate has likewise been observed between native
Australians and immigrants from Britain and immigrants from the rest
of Europe (121). No significant differences could be identified in the
Natal Province, but again the White population group is too small for
such a survey.
OCCUPATION 
There is evidence for the association of industrial factors
with the induction of malignant melanoma : cutaneous melanomas in
workers exposed to polychlorinated biphenyl (122), increases in melanomas
rates in chemists (123), but these reports have been based on very small
numbers. An excess of malignant melanomas has been reported among
workers at the US Lawrence Livermore National Laboratory dealing with
nuclear research for both civil and military purposes. The distribution
by anatomic sites was not different from a general population.
These findings are currently under investigation, but there
are no other reports of such findings in other nuclear laboratories.
TIME TRENDS 
ANATOMIC SITE - MELANOMA TYPE - HISTOLOGY 
In the Natal White population, as reported elsewhere (84,107)
the rising trend of the incidence of cutaneous melanoma in not homo-
geneous by anatomic site. Rates for head and neck lesions increase
more slowly than those of the trunk and limbs. The dissociation
i mposes constraints on hypotheses about the cause of such a rise; it
rules out systemic affects unless their action is coupled with site-
specific factors or unless they act on a specific target. Similarly,
it rules out hypotheses brought up to account for the homogeneity of
simultaneous anatomic distributions in widely different rates, in terms
of a "solar circulating factor".
Conversely this anatomic site effect could theorically be
explained by recent changes in personal habits. The face has to be
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exposed, and hats are worn less than in the past by urban dwellers,
although people involved in outdoor activities in South Africa still
favour the protection they give. Any change to usually exposed site
may produce little increment because of the point on the sigmoid
dose-response curve at which they start, whereas exposure of a usually
covered area of skin, like the trunk may produce a proportionally
l arger increase in incidence. Such an explanation pre-supposes that
the occurrence of melanoma is dose-related, which is hypothetical.
NON-CUTANEOUS SITES
Incidence and mortality rates for non-cutaneous sites have
remained identical over the years. Apparently, eye melanomas
respond to the same hormonal influences as do cutaneous ones, but do
not show the same latitude gradient (124).
The time trends of other melanomas unlikely to be influenced
by exposure would provide a further check on the hypothesis that the
incidence rise of skin melanomas is the direct result of exposure. There
is unfortunately no available data on internal melanomas.
It does not appear, however, that there is a rise in incidence
of acral melanomas, at least in White population groups, and they have
a high mean age, which further suggest that their incidence is not rising
through a year-of-birth effect.
NON MELANOMA SKIN CANCERS 
If the rising incidence of malignant melanomas is due to
increased exposure to sunlight, it can be assumed that this trend
applies also to other skin cancers. It is however, difficult to as-
certain that such a rise occurs; since they do not usually have a fatal
prognosis and their treatment is a simple matter, many cases are not
reported and therefore not included in statistics.
Yet from 1975 to 1982 the number of patients presenting with
either basal cell or squamous cell carcinomas, or both, and referred to
79.




Trauma has diversely been considered as an aetiological factor
of melanoma. Seldom reported by White persons as the incident which
initiated the occurrence of the lesion, it is frequently mentioned by
Blacks.
Hewer (90) regarded trauma as the most likely aetiology. Lewis,
in Uganda (18) assumes that physical or chemical agents might be
responsible for the malignant changes which take place in melanocytic
naevi of the plantar skin, namely heat and wood smoke. Wood is
without doubt the most used fuel by the Black population as freely
available, but the concentration of substances like dimethylbenzen-
thracene in wood smoke is not known; he also mentions application of
hot nails as treatment to lesions of the foot (and elsewhere).
Such practice could not be traced amongst Zulus, but Witch-Doctors
endeavour to keep their technique a well-guarded secret.
Krementz (82), reviewing all cases of melanoma in Negroes
treated at the Charity Hospital of Louisanna could find no evidence to
support the view that trauma may bear responsibility in the occurrence
of melanoma.
In the present survey, as previously mentioned, 16,2% of
the patients related the tumour to previous trauma.
The diversity of opinion may be explained by the socio-
economic differences of the population groups studied. American
Blacks are fully integrated in a White society and follow the
same habits and fashions as Whites; shoe wearing certainly minimizes
the risk of trauma.
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Conversely, the African Negro, even when urbanized, still abide by
his tribal customs; shoe wearing is not the rule in rural areas,
and certainly does not apply to children; even urban dwellers
not uncommonly dispense with this expensive fashion and when
wearing shoes these are often so ill-fitting that they are likely
to create more harm than preventing eventual trauma.
In sub-tropical climates like in Natal, the plantar skin
is subjected to constant high temperatures most of the year, not
only through direct contact with the ground itself when walking
barefoot, but also to high ambiant temperature when wearing shoes.
Five patients accepted to wear in their shoe, in contact
with the plantar skin, a sensitive probe. The temperatures
recorded during the peak hot season varied between 42° and 47,3 4
centigrade, more than is needed to induce protein alterations.
INTEGRATION OF FINDINGS - AN AETIOLOGIC HYPOTHESIS
Europeans and Bantus live in South Africa under the same
climatic conditions, as do Coloureds and Indians. Yet, during the
period covered in the survey, only two Indians and one Coloured
presented with a melanoma, precluding any study of the disease in
these two population groups. This is a disturbing finding :
one would expect Coloured people to show an incidence rate anywhere
between that of the Bantus and Europeans or similar to either one
of the two groups according to their degree of skin pigmentation,
if indeed melanin was acting as a sun-screen. The White population
of Natal, although living under near similar climatic conditions as
the Australian Queensland population, shows an appreciably lower
incidence rate of melanoma; the similarity goes beyond geographical
features and applies to clothing fashion as well as outdoor activities
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and socio-economic status. If sun exposure was the main factor in
inducing malignant changes in melanocytes, regions of the almost
permanently exposed to UV radiations beside the face - like the
forearm, seldom covered through short-sleeve shirt wearing, a
popular fashion in South Africa, or the dorsum of the hand, should
have a high incidence of melanoma. This is not so, although they
present a high rate of basal cell and squamous cell carcinomas. The
advanced age at which non-melanoma skin cancers appear, the histories
of prolonged exposure, whether occupational or recreational, the
clinical and histologic evidence of actinic damage to surrounding skin,
the concentration of lesions on exposed sites, are features of non-
melanomas but not of melanomas (25,125,126). Only the lentigo maligna
type bears similitude in its environmental relationship with non-
melanoma skin cancers and it seems reasonable to assume that the
pathogenesis of lentigo maligna melanoma is akin to that of basal cell
carcinoma. Likewise the age distribution, clinical appearance and
behaviour of acquired melanocytic naevi differ from those of solar
keratoses.
Ten Seldan (127) commented in 1962 : "Excessive exposure of
a sensitive skin to sunlight seems to he one of those aetiological
factors in the causation of malignant melanoblastomas. How important
has still to be assessed. It is unlikely that sunlight plays a major
part in all cases; or even the majority."
Sixteen years later (115), it was said, "Taken together these
findings suggest that the recognition of sunlight as the only important
risk factor of cutaneous melanoma may be an over simplification of a
complex problem." It may be that non-melanoma skin cancers require a
l ong exposure to sunlight whereas melanomas would necessitate a lower
dose in conjunction with other factors. But if all that is needed to
induce a melanoma is a small dose of UV radiation, the relative rarity
of the tumour is difficult to explain. Two possible explanations have
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been proposed : variation in exposure intensity and age at exposure.
It has been postulated that outdoor workers do not present a
high incidence rate because they are protected by a long acquired tan,
and that the determinant factor is intermittent exposure of untanned
skin to intense sunlight. Although this may well be true of
Europeans, who get exposure during brief holiday times, such an
explanation does not apply to South Africans, nor is it likely to
apply to Australians.
The association of naevi with melanoma and the occurrence
of melanocytic naevi during adolescence suggest that responsible
events which determine the subsequent growth of a lesion may well take
place early in life, in much the same way as early reproductive activity
determines breast cancer incidence. If the events during adolescence
play a major role in the long term induction of a melanoma, the low
incidence rate in outdoor workers could be explained. All these
speculations, however, are attempts at finding an explanation for the
occurrence of melanoma in White populations only. They exclude not
only other racial groups but also animals (28); yet it is difficult
to believe that the melanocyte would respond to a variety of factors,
or their interaction, in always the same pattern, unless these factors
always have a direct action on a specific target component of the cell.
The only components of the melanocyte which differentiate this cell
from others is the melanin and the enzymatic apparatus for its synthesis.
Vitiligo is a common occurrence in patients who survive a melanoma and
therefore have build-up an immunity against the affection : melanin
disappears; Albino patients, whose melanocytes lack totally or partially
the ability to synthetize melanin, do not develop melanomas (129,130),
and only eight cases of cutaneous melanomas have been reported in such
people. Although we see many of these patients each year for treatment
to basal or squamous skin cancers, no one ever presented a melanoma.
The implications of these findings are three-fold : melanin is not a
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sun-screen, else these patients would present multiple melanotic
tumours; sunlight alone is not the main causative factor; melanin-
or melanoprotein - is necessary for a melanoma to develop. In this
concept, heat is presumed to be the main factor responsible for
inducing alterations in the structure of the melanoprotein molecule,
which would then act as a pro-carcinogen. This hypothesis allows for
an explanation to the following :-
- the occurrence of melanoma in both White and Black populations
could be related to sunlight, not through a direct action in
terms of UV radiations, but in thermal energy received, and the
differential accumulation of such energy in melanocytic benign
l esions.
- the correlation between the high incidence of melanocytic naevi
of the Negroes' feet and the parallel incidence of melanoma,
both of which are prevalent at the pressure points.
- the controversy as whether we deal with a dose-dependant car-
cinogen : a fair skin briefly exposed to intense sun exposure
will burn more readily than a tanned skin which has had time to
become more resistant.
The fairly unusual occurrence of amelanotic lesions does not in-
validate the hypothesis : it is common for a primary lesion to give
rise to amelanotic metastases; the host's immune system may be held
responsible for the elimination of the pro-carcinogen, without being
able to control further growth.
It has been shown (131) that most cancers develop in multiple
steps. As normal cells evolve into cancer cells, several stages of
development take place from initiated cells to pre-neoplastic cells to
malignant cells, (132) as demonstrated in a mode of skin carcino-genesis
in mice (133), where an initiated cell can give rise to a skin cancer
after action of a promoter.
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Whether the structural alteration of the melanoprotein molecule
could subsequently give rise to a malignant melanoma would be circum-
stantial. Repeated trauma at the site, as occurring repeatedly on the
sole of the foot or the volar aspect of fingers and hand, with the
subsequent increase in mitotic activity, is a likely promoter, as well
as melanocyte hormonal stimulation by STH and ACTH as a response to
light exposure (and fair skinned persors present a more intense stimulation),
or even a stress situation, a prerogative which parallels social status.
In this context, it must be remembered that sustained specific growth
stimulation of a cell through application of its normal stimulant, can
induce tumours even without extrinsic carcinogenic agent, and that
tumours so induced are specific for the hyperstimulated cell type.
Such tumours soon become autonomous and fully hormone independant.
In our present knowledge, this hypothesis cannot besubstantiated
by experimental study since the extraction process of the molecule of
melanine itself induces structural alterations.* Histology, to date,
has failed to reveal any salient difference between normal and abnormal
melanocyte, which could result from molecular alterations, nor have
any changes which could be related to such causative factor been
exposed in electron microscopy, despite sophiscated and meticulous studies
(22).
As with many cancers, the final outcome depends upon the host's
i mmune system : the now malignant cell could simply be destroyed as soon
as produced, or could remain in a latent state until such time that
i mmunosurveillance deteriorates, as happens as age advances, or, through
total lack of immune response, would rapidly give rise to a clinical
tumour. (Fig. IV).





































Malignant melanoma has long been considered an unpredictable
cancer carrying a poor prognosis. Such pessimism is not justified.
The study has revealed aspects of the disease which had not
previously been investigated: the incidence increase in both Black and
White populations of the Natal Province, the very low rate amongst
Coloured and Indians groups. More important, the melanocytic naevi
surveys enlighten the relationship between such benign lesions and
melanomas, (whereas previous studies had been concerned with limited
aspects of such association), and the corollary, a new hypothesis in
an attempt to explain the occurence of malignancy. As regards
treatment, it is hoped that the results obtained with BCG therapy will
cast a new light on the subject. Further, the classification which has
been proposed should help in predicting the outcome of the affection, and
the treatment adapted individually. Where "low risk" patients may be
adequately treated by surgery alone, moderate and high risk patients
conversely can only benefit from immunotherapy eventually combined with
chemotherapy. In fact, the results obtained with immunotherapy in
patients who respond positively to this form of therapy is such that the
following modality in these selected cases should be considered :
i mmunotherapy, combined when deemed necessary with chemotherapy, as a
first line of treatment, which could lead to two eventualities : either
the lesion disappears entirely and nothing further need to be done, or
the lesion regresses to such an extent that a limited excision with primary
skin closure becomes feasible.
Although the present series of patients is comparable in
numbers to many series published elsewhere, it is nevertheless impossible
to prove beyond all doubts that this might be the best form of treatment.
Only data collected randomly from thousands of patients of same racial
groups, age, region of residence, presenting a similar type of melanoma
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of identical level of invasion and thickness could give a definite answer.
This is not feasible, except at international level, but the conclusions
presented seem reasonable.
To adopt a stereotyped therapeutic approach in dealing with
melanoma, clearly does not take into account the peculiarities either
of the patient or of a given type of tumour. Further, to apply today a
surgical treatment devised almost a century ago to excise extensive
l esions which are now seldom seen is not justifiable, even less so when
it becomes evident that no survival improvement may be expected by a more
radical and mutilating surgery. Four factors have emerged which are
considered of importance, the level of invasion of the tumour, its
thickness, its type and patients response to immunotherapy, with their
corresponding significance. Of these, only level of invasion and tumour
thickness depend upon the host's awareness; it is hoped that more and
more patients, through better knowledge, will seek medical attention
at an earlier stage.
Epidemiology uses the past to predict the future and considers
extreme situations in an attempt to explain the more common. To
achieve these goals, studies must include the greatest possible number
of patients and extend over the greatest possible periods. The
difficulties encountered in collecting data for the present survey
emphasize the need for a Cancer Registry in our country, and possibly










I. Tumour involving the whole
upper lip
II. Ulceration through the nail.
Tumour involving the whole
distal phalanx
III. Extensive ulcerated lesion of the
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